Document:

EXHIBIT 10.2

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION
RIGHTS AGREEMENT (this “Agreement”), dated as of December 31, 2021, is by and among SharpLink Gaming Ltd,
an Israeli company (the “Company”), and 6t4 Company, a Minnesota corporation (“6t4”)
and Chris Carlson (“Carlson”, and with 6t4, the “Sellers” and individually, a “Seller”).

 

RECITALS

 

A.          In
connection with the Asset Purchase Agreement by and among the Company, FourCubed Acquisition Company, LLC, FourCubed Management,
LLC and the Sellers, dated as of the date hereof (the “Asset Purchase Agreement”), the Company has agreed, upon
the terms and subject to the conditions of the Asset Purchase Agreement, to issue to 6t4 as partial consideration for the purchase
of 6t4’s assets (i) 606,114 Ordinary Shares on or about January 5, 2022 (the “Stock Payment Shares”) and
(ii) 587,747 additional Ordinary Shares upon meeting certain business and financial milestones following the Closing as the Earnout
Payment under the Asset Purchase Agreement (the “Earnout Payment Shares” and together with the Stock Payment
Shares, the “6t4 Shares”).

 

B.          To
induce the Sellers to consummate the transactions contemplated by the Asset Purchase Agreement, the Company has agreed to provide
certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar
successor statute (collectively, the “1933 Act”).

 

AGREEMENT

 

NOW, THEREFORE,
in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and each of the Sellers hereby agree as follows:

 

	 	1.	Definitions.

 

Capitalized terms
used herein and not otherwise defined herein shall have the respective meanings set forth in the Asset Purchase Agreement. As used
in this Agreement, the following terms shall have the following meanings:

 

(a)         
“Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in Minneapolis,
Minnesota or New York, New York are authorized or required by law to remain closed.

 

(b)          “Closing
Date” shall have the meaning set forth in the Asset Purchase Agreement.

 

(c)          “Company
Counsel” means Fredrikson & Byron, P.A., Minneapolis, Minnesota.

 

    	 

    	 

    

 

(d)          “Effective
Date” means the date that the applicable Registration Statement has been declared effective by the SEC.

 

(e)          “Effectiveness
Deadline” means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a),
the earlier of the (A) 90th calendar day after the Filing Deadline (or the 120th calendar day after the Filing
Deadline in the event that such Registration Statement is subject to Full Review by the SEC), and (B) the fifth day after the date
the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed
or will not be subject to further review, and (ii) with respect to any additional Registration Statements that may be required
to be filed by the Company pursuant to this Agreement, the earlier of the (A) 90th calendar day following the date on which the
Company was required to file such additional Registration Statement and (B) the fifth day after the date the Company is notified
(orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject
to further review.

 

(f)          “Filing
Deadline” means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a),
the 10th Trading Day after the expiration of the Lock-Up Period for the Stock Payment Shares as provided herein and (ii) with respect
to any additional Registration Statements that may be required to be filed by the Company pursuant to this Agreement, the date
on which the Company was required to file such additional Registration Statement pursuant to the terms of this Agreement.

 

(g)          “Full
Review” in respect of any Registration Statement shall mean an instance where the staff of the SEC does not inform the
Company either that the Registration Statement will not be reviewed or that such review will be on a limited, monitor or expedited
(or other similar) basis.

 

(h)          “Investor”
means a Seller or any transferee or assignee of any Registrable Securities to whom a Seller assigns its rights under this Agreement
(including Registrable Securities transferred by 6t4 to Carlson) and who agrees to become bound by the provisions of this Agreement
in accordance with Section 9 and any transferee or assignee thereof to whom a transferee or assignee of any Registrable Securities
assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with
Section 9.

 

(i)          ““Lock-Up
Period” means that unless Parent otherwise consents in writing, which consent may be given or withheld in Parent’s
sole discretion, all Ordinary Shares issued to the Sellers to the Asset Purchase Agreement shall be subject to the following restrictions:
(1) no Ordinary Shares may be sold or otherwise transferred for a period of six (6) months following their issuance; and (2) following
such six (6)-month period, only twenty five percent (25%) of each Stock Payment Shares may be resold or transferred each month
thereafter.

 

(j)          “Ordinary
Shares” means the Company’s ordinary shares, par value NIS 0.006 per share, or share shares of capital stock into
which such ordinary shares are converted or exchanged in any merger, reclassification, recapitalization or similar event, including
a merger effected for the purpose of reincorporating the Company under the laws of a state in the United States.”

 

    	-2-

    	 

    

 

(k)          “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization
or a government or any department or agency thereof.

 

(l)           “register,”
“registered,” and “registration” refer to a registration effected by preparing and filing
one or more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 and the declaration of effectiveness
of such Registration Statement(s) by the SEC.

 

(m)         “Registrable
Securities” means (i) the 6t4 Shares and (ii) any capital stock of the Company issued or issuable with respect to the
6t4 Shares, including without limitation, (1) as a result of any stock split, stock dividend, recapitalization, exchange or similar
event or otherwise (2) shares of capital stock of the Company into which the Ordinary Shares are converted or exchanged and shares
of capital stock of a successor entity (including, without limitation, upon conversion of the Company from an Israeli company to
a Delaware corporation) into which the Ordinary Shares are converted or exchanged and (3) any shares issued or issuable by the
Company as Registration Delay Payments pursuant to Section 2(d) hereunder, provided, however, that Registrable Securities
shall not include any securities of the Company that have previously been registered and remain subject to a currently effective
registration statement or which have been sold to the public either pursuant to a registration statement or Rule 144, or which
have been sold in a private transaction in which the transferor’s rights under this Section 1 are not assigned, or which
may be sold immediately without registration under the Securities Act and without volume restrictions pursuant to Rule 144.

 

(n)          “Registration
Statement” means a registration statement or registration statements of the Company filed under the 1933 Act covering
the resale of the Registrable Securities by the Investors.

 

(o)          “Required
Holders” means the holders of at least a majority of the Registrable Securities.

 

(p)          “Required
Registration Amount” means the Registrable Securities required to be registered hereunder, being, with respect to the
initial Registration Statement to be filed pursuant to Section 2(a) hereunder, the number of shares constituting the Stock Payment
Shares and, with respect to any subsequent Registration Statement to be filed hereunder, the number of shares constituting the
Earnout Payment Shares.

 

(q)          “Rule
144” means Rule 144 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any
other similar or successor rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company
to the public without registration.

 

    	-3-

    	 

    

 

(r)           “Rule
415” means Rule 415 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any
other similar or successor rule or regulation of the SEC providing for offering securities on a continuous or delayed basis.

 

(s)         
“SEC” means the United States Securities and Exchange Commission or any successor thereto.

 

(t)           “Trading
Day” means a day on which the principal Trading Market is open for trading.

 

(u)          “Trading
Market” means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).

 

	 	2.	Registration.

 

(a)          Mandatory
Registration. The Company shall prepare and file with the SEC, on or before the Filing Deadline, an initial Registration Statement
on Form F-3 or S-3 (or such other form then available to the Company to register the resale of the Registrable Securities), or
the largest amount thereof permissible; provided that such initial Registration Statement shall register for resale at least the
number of Ordinary Shares equal to the Required Registration Amount as of the date such Registration Statement is initially filed
with the SEC. Such initial Registration Statement, and each other Registration Statement required to be filed pursuant to the terms
of this Agreement, shall contain (except if otherwise directed by the Required Holders) the “Selling Stockholders”
and “Plan of Distribution” sections in substantially the form attached hereto as Exhibit A. The
Company shall use its reasonable best efforts to have such initial Registration Statement, and each other Registration Statement
required to be filed pursuant to the terms of this Agreement, declared effective by the SEC as soon as practicable thereafter.

 

(b)         Sufficient
Number of Shares Registered. In the event the number of shares available under any Registration Statement is insufficient to
cover all of the Registrable Securities required to be covered by such Registration Statement or an Investor’s allocated
portion of the Registrable Securities pursuant to Section 2(f), the Company shall amend such Registration Statement (if permissible),
or file with the SEC a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover
at least the Required Registration Amount as of the Trading Day immediately preceding the date of the filing of such amendment
or new Registration Statement, in each case, as soon as practicable, but in any event not later than fifteen (15) days after the
necessity therefor arises (but taking account of any Staff position with respect to the date on which the Staff will permit such
amendment to the Registration Statement and/or such new Registration Statement (as the case may be) to be filed with the SEC).
The Company shall use commercially reasonable efforts to cause such amendment to such Registration Statement and/or such new Registration
Statement (as the case may be) to become effective as soon as practicable following the filing thereof with the SEC. For purposes
of the foregoing provision, the number of shares available under a Registration Statement shall be deemed “insufficient to
cover all of the Registrable Securities” if at any time the number of Ordinary Shares available for resale is insufficient.

 

    	-4-

    	 

    

 

(c)           Offering.
Notwithstanding anything to the contrary contained in this Agreement, in the event the Staff or the SEC seeks to characterize any offering
pursuant to a Registration Statement filed pursuant to this Agreement as constituting an offering of securities by, or on
behalf of, the Company, or in any other manner, such that the Staff or the SEC do not permit such Registration Statement
to become effective and used for resales in a manner that does not constitute such an offering and that permits the continuous
resale at the market by the Investors participating therein (or as otherwise may be acceptable to each Investor) without
being named therein as an “underwriter,” then the Company shall reduce the number of shares to be included in such
Registration Statement by all Investors until such time as the Staff and the SEC shall so permit such Registration Statement
to become effective as aforesaid. In making such reduction, the Company shall reduce the number of shares to be included by
all Investors on a pro rata basis (based upon the number of Registrable Securities otherwise required to be included for each Investor)
unless the inclusion of shares by a particular Investor or a particular set of Investors are resulting in the Staff or the SEC’s “by
or on behalf of the Company” offering position, in which event the shares held by such Investor or set of Investors shall
be the only shares subject to reduction (and if by a set of Investors on a pro rata basis by such Investors or on such other basis
as would result in the exclusion of the least number of shares by all such Investors).  In addition, in the event that the
Staff or the SEC requires any Investor seeking to sell securities under a Registration Statement filed pursuant to this Agreement to
be specifically identified as an “underwriter” in order to permit such Registration Statement to become effective,
and such Investor does not consent to being so named as an underwriter in such Registration Statement, then, in each such
case, the Company shall reduce the total number of Registrable Securities to be registered on behalf of such Investor, until
such time as the Staff or the SEC does not require such identification or until such Investor accepts such identification and the
manner thereof. Any reduction pursuant to this paragraph will first reduce all securities that are not Registrable Securities,
if any such securities are permitted by the Required Holders to be included in accordance with the terms of this Agreement. In
the event of any reduction in Registrable Securities pursuant to this paragraph, an affected Investor shall have the
right to require, upon delivery of a written request to the Company signed by such Investor, the Company to file a registration
statement within thirty (30) calendar days of such request (subject to any restrictions imposed by Rule 415 or required by
the Staff or the SEC) for resale by such Investor in a manner acceptable to such Investor, and the Company shall following
such request cause to be and keep effective such registration statement in the same manner as otherwise contemplated in
this Agreement for registration statements hereunder, in each case, until such time as: (i) all Registrable Securities held
by such Investor have been registered and sold pursuant to an effective Registration Statement in a manner acceptable to such
Investor or (ii) all Registrable Securities may be resold by such Investor without restriction (including, without limitation,
volume limitations) pursuant to Rule 144 (taking account of any Staff position with respect to “affiliate” status)
and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or (iii) such
Investor agrees to be named as an underwriter in any such Registration Statement in a manner acceptable to such Investor as to
all Registrable Securities held by such Investor and that have not theretofore been included in a Registration Statement under
this Agreement (it being understood that the special demand right under this sentence may be exercised by an Investor multiple
times and with respect to limited amounts of Registrable Securities in order to permit the resale thereof by such Investor as contemplated
above). Any reduction made to securities included in a Registration Statement in accordance with this Section 2(e) shall not constitute
a breach of the Company’s obligations hereunder.

 

    	-5-

    	 

    

 

(d)           Allocation
of Registrable Securities. The initial number of Registrable Securities included in any Registration Statement and any increase
in the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number of
Registrable Securities held by each Investor at the time such Registration Statement covering such initial number of Registrable
Securities or increase thereof is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any
of such Investor’s Registrable Securities, each transferee or assignee (as the case may be) that becomes an Investor shall
be allocated a pro rata portion of the then-remaining number of Registrable Securities included in such Registration Statement
for such transferor or assignee (as the case may be). Any Ordinary Shares included in a Registration Statement and which remain
allocated to any Person which ceases to hold any Registrable Securities covered by such Registration Statement shall be allocated
to the remaining Investors, pro rata based on the number of Registrable Securities then held by such Investors which are covered
by such Registration Statement.

  

	 	3.	Related
    Obligations.

 

The Company shall
use its best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition
thereof, and, pursuant thereto, the Company shall have the following obligations:

 

(a)           Subject
to Allowable Grace Periods, the Company’s obligations with respect to each Investor to file and maintain the effectiveness
of each Registration Statement (and the prospectus contained therein available for use) pursuant to Rule 415 for resales by the
Investors on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all times until the earlier
of (i) the date when such Investor may sell all of the Registrable Securities required to be covered by such Registration Statement
(disregarding any reduction pursuant to Section 2(e)) without restriction pursuant to Rule 144 (including, without limitation,
volume restrictions) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable)
or (ii) the date on which such Investor shall have sold all of the Registrable Securities covered by such Registration Statement
(the “Registration Period”). Notwithstanding anything to the contrary contained in this Agreement, the Company
shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all
amendments and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto)
used in connection with such Registration Statement (1) shall not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the
light of the circumstances in which they were made) not misleading and (2) will disclose (whether directly or through incorporation
by reference to other SEC filings to the extent permitted) all material information regarding the Company and its securities.

 

    	-6-

    	 

    

 

(b)           Subject
to Section 3(o) of this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation,
post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each such
Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the 1933 Act, as may be necessary
to keep each such Registration Statement effective at all times during the Registration Period for such Registration Statement,
and, during such period, comply with the provisions of the 1933 Act with respect to the disposition of all Registrable Securities
of the Company required to be covered by such Registration Statement until such time as all of such Registrable Securities shall
have been disposed of in accordance with the intended methods of disposition by the Investors as set forth in such Registration
Statement; provided, however, by 9:30 a.m. (New York time) no later than the second Business Day immediately following each Effective
Date, the Company shall file with the SEC in accordance with Rule 424(b) under the 1933 Act the final prospectus to be used in
connection with sales pursuant to the applicable Registration Statement (whether or not such a prospectus is technically required
by such rule). In the case of amendments and supplements to any Registration Statement which are required to be filed pursuant
to this Agreement (including, without limitation, pursuant to this Section 3(b)) by reason of the Company filing a report on Form
6-K, Form 20-F, Form 10-K, Form 10-Q, Form 8-K or any analogous report under the Securities Exchange Act of 1934, as amended (the
“1934 Act”), the Company shall have incorporated such report by reference into such Registration Statement,
if applicable, or shall file such amendments or supplements with the SEC on the same day on which the 1934 Act report is filed
which created the requirement for the Company to amend or supplement such Registration Statement.

 

(c)           The
Company shall (i) permit a person designated by the Required Holders to review and provide comments to the Company and Company
Counsel, with respect to (A) each Registration Statement at least two (2) Business Days prior to its filing with the SEC and (B)
all amendments and supplements to each Registration Statement (including, without limitation, the prospectus contained therein)
(except for Reports on Form 6-K, Form 20-F, Form 10-K, Form 10-Q, Form 8-K, and any similar or successor reports) within a reasonable
number of days prior to their filing with the SEC, and (ii) not file any Registration Statement or amendment or supplement thereto
in a form to which the designee of the Required Holders reasonably objects.

 

(d)           [RESERVED]

 

(e)           [RESERVED]

 

(f)           The
Company shall either notify each Investor in writing or file a current Report on Form 6-K or 8-K with the SEC providing disclosure
of the happening of any event, as promptly as practicable after becoming aware of such event, as a result of which the prospectus
included in a Registration Statement, as then in effect, includes an untrue statement of a material fact or omission to state a
material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading (provided that in no event shall such notice contain any material, non-public information
regarding the Company or any of its Subsidiaries), and, subject to Section 3(o), promptly prepare a supplement or amendment to
such Registration Statement and such prospectus contained therein to correct such untrue statement or omission and file such supplement
or amendment with the SEC. The Company shall also promptly notify each Investor in writing (i) when a prospectus or any prospectus
supplement or post-effective amendment has been filed, when a Registration Statement or any post-effective amendment has become
effective (notification of such effectiveness shall be delivered to each Investor by facsimile or e-mail on the same day of such
effectiveness and by overnight mail), and when the Company receives written notice from the SEC that a Registration Statement or
any post-effective amendment will be reviewed by the SEC, (ii) of any request by the SEC for amendments or supplements to a Registration
Statement or related prospectus or related information, (iii) of the Company’s reasonable determination that a post-effective
amendment to a Registration Statement would be appropriate; and (iv) of the receipt of any request by the SEC or any other federal
or state governmental authority for any additional information relating to the Registration Statement or any amendment or supplement
thereto or any related prospectus. The Company shall respond as promptly as practicable to any comments received from the SEC with
respect to each Registration Statement or any amendment thereto (it being understood and agreed that the Company’s response
to any such comments shall be delivered to the SEC no later than ten (10) Business Days after the receipt thereof).

 

    	-7-

    	 

    

 

(g)           The
Company shall (i) use its reasonable best efforts to prevent the issuance of any stop order or other suspension of effectiveness
of each Registration Statement or the use of any prospectus contained therein, or the suspension of the qualification, or the loss
of an exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or
suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and (ii) notify each
Investor who holds Registrable Securities of the issuance of such order and the resolution thereof or its receipt of actual notice
of the initiation or threat of any proceeding for such purpose.

 

(h)           [RESERVED]

 

(i)            If
any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and
such Investor consents to so being named an underwriter, upon the written request of such Investor, the Company shall make available
for inspection by (i) such Investor, (ii) legal counsel for such Investor and (iii) one (1) firm of accountants or other agents
retained by such Investor (collectively, the “Inspectors”), all pertinent financial and other records, and pertinent
corporate documents and properties of the Company (collectively, the “Records”), as shall be reasonably deemed
necessary by each Inspector, and cause the Company’s officers, directors and employees to supply all information which any
Inspector may reasonably request; provided, however, each Inspector shall agree in writing to hold in strict confidence and not
to make any disclosure (except to such Investor) or use of any Record or other information which the Company’s board of directors
determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (1) the disclosure
of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required
under the 1933 Act, (2) the release of such Records is ordered pursuant to a final, non-appealable subpoena or order from a court
or government body of competent jurisdiction, or (3) the information in such Records has been made generally available to the public
other than by disclosure in violation of this Agreement or any other Transaction Document (as defined in the Asset Purchase Agreement).
Such Investor agrees that it shall, upon learning that disclosure of such Records is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company, at its expense, to undertake
appropriate action to prevent disclosure of, or to obtain a protective order for, the Records deemed confidential. Nothing herein
(or in any other confidentiality agreement between the Company and such Investor, if any) shall be deemed to limit any Investor’s
ability to sell Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations.

 

    	-8-

    	 

    

 

(j)            The
Company shall hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed
in such Registration Statement pursuant to the 1933 Act, (iii) the release of such information is ordered pursuant to a subpoena
or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has
been made generally available to the public other than by disclosure in violation of this Agreement or any other Transaction Document.
The Company agrees that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a
court or governmental body of competent jurisdiction or through other means, give prompt written notice to such Investor and allow
such Investor, at such Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, such information.

 

(k)           [RESERVED]

 

(l)            To
the extent that any registration statement filed pursuant to this Agreement has been declared effective by the SEC, then the Company
shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the
timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to
be offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts (as the case
may be) as the Investors may reasonably request from time to time and registered in such names as the Investors may request, or,
if requested by an Investor and the Ordinary Shares is traded through the facilities of the DTC (as defined below), credit such
aggregate number of Registrable Securities to be offered by such Investor to such Investor’s or its designee’s balance
account with The Depository Trust Company (“DTC”) through its Deposit/Withdrawal at Custodian system.

 

(m)           If
reasonably requested by an Investor, the Company shall as soon as practicable after receipt of notice from such Investor and subject
to Section 3(o) hereof, (i) incorporate in a prospectus supplement or post-effective amendment such information as an Investor
reasonably requests to be included therein, but only as to which information the Company Counsel agrees (which agreement shall
not be unreasonably withheld), relating to the sale and distribution of Registrable Securities, including, without limitation,
information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor
and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of
such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus
supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement or prospectus contained
therein if reasonably requested by an Investor holding any Registrable Securities.

 

    	-9-

    	 

    

 

(n)          The
Company shall otherwise use its best efforts to comply with all applicable rules and regulations of the SEC in connection with
any registration hereunder.

 

(o)           Notwithstanding
anything to the contrary herein (but subject to the last sentence of this Section 3), at any time after the Effective Date of a
particular Registration Statement, the Company may delay the disclosure of material, non-public information concerning the Company
or any of its Subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of the
Company, in the best interest of the Company and, in the opinion of Company Counsel, otherwise required (a “Grace Period”),
provided that the Company shall promptly notify the Investors in writing of the (i) existence of material, non-public information
giving rise to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material, non-public
information to any of the Investors) and the date on which such Grace Period will begin and (ii) date on which such Grace
Period ends, provided further that (I) no Grace Period shall exceed twenty (20) consecutive days and during any three hundred sixty
five (365) day period all such Grace Periods shall not exceed an aggregate of forty-five (45) days, (II) the first day of any Grace
Period must be at least five (5) Trading Days after the last day of any prior Grace Period and (III) no Grace Period may exist
during the thirty (30) Trading Day period immediately following the Effective Date of such Registration Statement (provided that
such thirty (30) Trading Day period shall be extended by the number of Trading Days during such period and any extension thereof
contemplated by this proviso during which such Registration Statement is not effective or the prospectus contained therein is not
available for use) (each, an “Allowable Grace Period”). For purposes of determining the length of a Grace Period
above, such Grace Period shall begin on and include the date the Investors receive the notice referred to in clause (i) above and
shall end on and include the later of the date the Investors receive the notice referred to in clause (ii) above and the date referred
to in such notice. The provisions of the first sentence of Section 3(f) and the provisions of Section 3(g) hereof shall not be
applicable during the period of any Allowable Grace Period. Upon expiration of each Grace Period, the Company shall again be bound
by the first sentence of Section 3(f) and the provisions of Section 3(g) with respect to the information giving rise thereto unless
such material, non-public information is no longer applicable. Notwithstanding anything to the contrary contained in this Section
3, the Company shall cause its transfer agent to deliver unlegended Ordinary Shares to a transferee of an Investor in connection
with any sale of Registrable Securities with respect to which such Investor has entered into a contract for sale, and delivered
a copy of the prospectus included as part of the particular Registration Statement (unless an exemption from such prospectus delivery
requirement exists), prior to such Investor’s receipt of the notice of a Grace Period and for which the Investor has not
yet settled.

 

	 	4.	Obligations
    of the Investors.

 

(a)           At
least five (5) Business Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify
each Investor in writing of the information the Company requires from each such Investor with respect to such Registration Statement.
It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with
respect to the Registrable Securities of a particular Investor that such Investor shall furnish to the Company such information
regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held
by it, as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities
and shall execute such documents in connection with such registration as the Company may reasonably request.

 

    	-10-

    	 

    

 

(b)           Each
Investor, by such Investor’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably
requested by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless such Investor
has notified the Company in writing of such Investor’s election to exclude all of such Investor’s Registrable Securities
from such Registration Statement.

 

(c)           Each
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section
3(g) or the first sentence of 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to
any Registration Statement(s) covering such Registrable Securities until such Investor’s receipt of the copies of the supplemented
or amended prospectus contemplated by Section 3(g) or the first sentence of Section 3 or receipt of notice that no supplement or
amendment is required. Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause its transfer agent
to deliver unlegended Ordinary Shares to a transferee of an Investor in connection with any sale of Registrable Securities with
respect to which such Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the
Company of the happening of any event of the kind described in Section 3(g) or the first sentence of Section 3(f) and for which
such Investor has not yet settled.

 

(d)           Each
Investor covenants and agrees that it will comply with the prospectus delivery requirements of the 1933 Act as applicable to it
in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

	 	5.	Expenses
    of Registration.

 

All reasonable expenses,
other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant
to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting
fees, FINRA filing fees (if any), blue sky fees and fees and disbursements of counsel for the Company shall be paid by the Company.
The Company shall have no obligation to pay the expenses of any Investor incurred in connection with any registration, filing or
qualification pursuant to Sections 2 and 3 of this Agreement.

 

    	-11-

    	 

    

 

	 	6.	Indemnification.

 

(a)          To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor and each
of its directors, officers, shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons
with a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title)
and each Person, if any, who controls such Investor within the meaning of the 1933 Act or the 1934 Act and each of the directors,
officers, shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) of such controlling
Persons (each, an “Indemnified Person”), against any losses, obligations, claims, damages, liabilities, contingencies,
judgments, fines, penalties, charges, costs (including, without limitation, court costs, reasonable attorneys’ fees and costs
of defense and investigation), amounts paid in settlement or expenses, joint or several, (collectively, “Claims”)
incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from
the foregoing by or before any court or governmental, administrative or other regulatory agency, body or the SEC, whether pending
or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”), to
which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement of a material fact in a Registration Statement or any post-effective
amendment thereto or in any filing made in connection with the qualification of the offering under the securities or other “blue
sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”), or the
omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii)
any untrue statement of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration
Statement, or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement
thereto with the SEC) or the omission to state therein any material fact necessary to make the statements made therein, in light
of the circumstances under which the statements therein were made, not misleading or (iii) any violation by the Company of the
1933 Act, the 1934 Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder
relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement (the matters in the foregoing
clauses (i) through (iii) being, collectively, “Violations”). Subject to Section 6(c), the Company shall reimburse
the Indemnified Persons, promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable
expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary
contained herein, the indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Indemnified
Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing
to the Company by such Indemnified Person for such Indemnified Person expressly for use in connection with the preparation of such
Registration Statement or any such amendment thereof or supplement thereto and (ii) shall not be available to a particular Investor
to the extent such Claim is based on a failure of such Investor to deliver or to cause to be delivered the prospectus made available
by the Company (to the extent applicable), including, without limitation, a corrected prospectus, if such prospectus or corrected
prospectus was timely made available by the Company pursuant to Section 3(d) and then only if, and to the extent that, following
the receipt of the corrected prospectus no grounds for such Claim would have existed; and (iii) shall not apply to amounts paid
in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall
not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless of any investigation made
by or on behalf of the Indemnified Person and shall survive the transfer of any of the Registrable Securities by any of the Investors
pursuant to Section 9.

 

    	-12-

    	 

    

 

(b)          In
connection with any Registration Statement in which an Investor is participating, such Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each
of its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within
the meaning of the 1933 Act or the 1934 Act (each, an “Indemnified Party”), against any Claim or Indemnified
Damages to which any of them may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified
Damages arise out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation
occurs in reliance upon and in conformity with written information furnished to the Company by such Investor expressly for use
in connection with such Registration Statement; and, subject to Section 6(c) and the below provisos in this Section 6(b), such
Investor will reimburse an Indemnified Party any legal or other expenses reasonably incurred by such Indemnified Party in connection
with investigating or defending any such Claim; provided, however, the indemnity agreement contained in this Section 6(b) and the
agreement with respect to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such
settlement is effected without the prior written consent of such Investor, which consent shall not be unreasonably withheld or
delayed, provided further that such Investor shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified
Damages as does not exceed the net proceeds to such Investor as a result of the applicable sale of Registrable Securities pursuant
to such Registration Statement. Such indemnity shall remain in full force and effect regardless of any investigation made by or
on behalf of such Indemnified Party and shall survive the transfer of any of the Registrable Securities by any of the Investors
pursuant to Section 9.

 

(c)          Promptly
after receipt by an Indemnified Person or Indemnified Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Indemnified
Person or Indemnified Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party
under this Section 6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party
shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party
and the Indemnified Person or the Indemnified Party (as the case may be); provided, however, an Indemnified Person or Indemnified
Party (as the case may be) shall have the right to retain its own counsel with the fees and expenses of such counsel to be paid
by the indemnifying party if: (i) the indemnifying party has agreed in writing to pay such fees and expenses; (ii) the indemnifying
party shall have failed promptly to assume the defense of such Claim and to employ counsel reasonably satisfactory to such Indemnified
Person or Indemnified Party (as the case may be) in any such Claim; or (iii) the named parties to any such Claim (including, without
limitation, any impleaded parties) include both such Indemnified Person or Indemnified Party (as the case may be) and the indemnifying
party, and such Indemnified Person or such Indemnified Party (as the case may be) shall have been advised by counsel that a conflict
of interest is likely to exist if the same counsel were to represent such Indemnified Person or such Indemnified Party and the
indemnifying party (in which case, if such Indemnified Person or such Indemnified Party (as the case may be) notifies the indemnifying
party in writing that it elects to employ separate counsel at the expense of the indemnifying party, then the indemnifying party
shall not have the right to assume the defense thereof and such counsel shall be at the expense of the Indemnifying Party, provided
further that in the case of clause (iii) above the indemnifying party shall not be responsible for the reasonable fees and expenses
of more than one (1) separate legal counsel for such Indemnified Person or Indemnified Party (as the case may be). 

 

    	-13-

    	 

    

 

The Indemnified
Party or Indemnified Person (as the case may be) shall reasonably cooperate with the indemnifying party in connection with any
negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information
reasonably available to the Indemnified Party or Indemnified Person (as the case may be) which relates to such action or Claim.
The indemnifying party shall keep the Indemnified Party or Indemnified Person (as the case may be) reasonably apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for
any settlement of any action, claim or proceeding effected without its prior written consent; provided, however, the indemnifying
party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent
of the Indemnified Party or Indemnified Person (as the case may be), consent to entry of any judgment or enter into any settlement
or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified
Party or Indemnified Person (as the case may be) of a release from all liability in respect to such Claim or litigation, and such
settlement shall not include any admission as to fault on the part of the Indemnified Party. Following indemnification as provided
for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person (as the
case may be) with respect to all third parties, firms or corporations relating to the matter for which indemnification has been
made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such
action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party (as the case may
be) under this Section 6, except to the extent that the indemnifying party is materially and adversely prejudiced in its ability
to defend such action.

 

(d)          No
Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the 1933 Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale
of Registrable Securities who is not guilty of fraudulent misrepresentation.

 

(e)          The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.

 

(f)          The
indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the
Indemnified Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party
may be subject to pursuant to the law.

 

    	-14-

    	 

    

 

	 	7.	Contribution.

 

To the extent any
indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution
with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law; provided,
however: (i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification under
the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which
Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) in connection with such
sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent
misrepresentation; and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount of net
proceeds received by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement.
Notwithstanding the provisions of this Section 7, no Investor shall be required to contribute, in the aggregate, any amount in
excess of the amount by which the net proceeds actually received by such Investor from the applicable sale of the Registrable Securities
subject to the Claim exceeds the amount of any damages that such Investor has otherwise been required to pay, or would otherwise
be required to pay under Section 6(b), by reason of such untrue statement or omission. Notwithstanding the foregoing, the contribution
agreement contained in this Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed.

 

	 	8.	Reports
    Under the 1934 Act.

 

With a view to making
available to the Investors the benefits of Rule 144, on and after the Closing Date and until the expiration of the Registration
Period, the Company agrees to:

 

(a)          make
and keep public information available, as those terms are understood and defined in Rule 144;

 

(b)          file
with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act so
long as the Company remains subject to such requirements (it being understood and agreed that nothing herein shall limit any obligations
of the Company under the Asset Purchase Agreement) and the filing of such reports and other documents is required for the applicable
provisions of Rule 144; and

 

(c)          furnish
to each Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,
if true, that it has complied with the reporting, submission and posting requirements of Rule 144 and the 1934 Act, (ii) a copy
of the most recent Form 20-F or 10-K of the Company and such other reports and documents so filed by the Company with the SEC if
such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to permit the
Investors to sell such securities pursuant to Rule 144 without registration.

 

    	-15-

    	 

    

 

	 	9.	Assignment
    of Registration Rights.

 

The rights to cause
the Company to register Registrable Securities pursuant to this Section 1 may be transferred or assigned, including by 6t4 to Carlson,
but only with all related obligations, by an Investor to a transferee or assignee.

 

	 	10.	Amendment
    of Registration Rights.

 

Provisions of this
Agreement may be amended only with the written consent of the Company and the Required Holders. Any amendment effected in accordance
with this Section 10 shall be binding upon each Investor and the Company, provided that no such amendment shall be effective to
the extent that it (1) applies to less than all of the holders of the holders of Registrable Securities, (2) imposes any obligation
or liability on any Investor without such Investor’s prior written consent (which may be granted or withheld in such Investor’s
sole discretion) or (3) applies retroactively. No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party, provided that the Required Holders (in a writing signed by all of the Required Holders) may
waive any provision of this Agreement, and any waiver of any provision of this Agreement made in conformity with the provisions
of this Section 10 shall be binding on each Investor, provided that no such waiver shall be effective to the extent that it (1)
applies to less than all the Investors (unless a party gives a waiver as to itself only) or (2) imposes any obligation or liability
on any Investor without such Investor’s prior written consent (which may be granted or withheld in such Investor’s
sole discretion). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any
provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.

 

	 	11.	Miscellaneous.

 

(a)          Solely
for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed
to own, of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two
or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or
election received from such record owner of such Registrable Securities.

 

(b)          Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be
in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent
by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending
party); (iii) with respect to Section 3(c), by e-mail (provided confirmation of transmission is electronically generated and kept
on file by the sending party); or (iv) one (1) Business Day after deposit with a nationally recognized overnight delivery service
with next day delivery specified, in each case, properly addressed to the party to receive the same. The addresses and facsimile
numbers for such communications shall be:

 

    	-16-

    	 

    

 

	If to the Company:	SharpLink Gaming Ltd.
	 	333 Washington Avenue North, Suite 104
	 	Minneapolis, Minnesota 55401

Email: rob.phythian@sharplink.com
	 	 
	With a copy to:	 
	(not constituting notice)	Fredrikson & Byron, P.A.
	 	200 South Sixth Street, Suite 4000

Minneapolis, Minnesota 55402
	 	Attn: Christopher J. Melsha, Esq.
	 	Email: cmelsha@fredlaw.com

 

If to a Seller, to
its address, facsimile number or e-mail address (as the case may be) set forth on the signature page for such Seller attached to
the Asset Purchase Agreement, with copies to such Seller’s representatives as set forth on the Schedule of Sellers, or to
such other address, facsimile number and/or e-mail address and/or to the attention of such other Person as the recipient party
has specified by written notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation
of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender’s facsimile machine or e-mail transmission containing the time, date and recipient facsimile number
or e-mail address or (C) provided by a courier or overnight courier service shall be rebuttable evidence of personal service, receipt
by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above,
respectively.

 

(c)          Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or
remedy, shall not operate as a waiver thereof.

 

(d)          All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of Minnesota, without giving effect to any choice of law or conflict of law provision or rule (whether of the
State of Minnesota or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the
State of Minnesota. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in Minneapolis, Minnesota for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an
inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such
party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such
invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction
or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    	-17-

    	 

    

 

(e)          This
Agreement, the Asset Purchase Agreement, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein (the “Transaction Documents”) constitute the entire agreement among the parties hereto and
thereto solely with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings,
other than those set forth or referred to herein and therein. This Agreement and other Transaction Documents supersede all prior
agreements and understandings among the parties hereto solely with respect to the subject matter hereof and thereof; provided,
however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect
on any agreements any Investor has entered into with, or any instrument that any Investor received from, the Company or any of
its subsidiaries prior to the date hereof with respect to any prior investment made by such Investor in the Company, (ii) waive,
alter, modify or amend in any respect any obligations of the Company or any of its subsidiaries or any rights of or benefits to
any Investor or any other Person in any agreement entered into prior to the date hereof between or among the Company and/or any
of its subsidiaries and any Investor or any instrument that any Investor received prior to the date hereof from the Company and/or
any of its subsidiaries and all such agreements and instruments shall continue in full force and effect or (iii) limit any obligations
of the Company under any of the other Transaction Documents.

 

(f)          Subject
to compliance with Section 9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted successors
and assigns of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced by,
any Person, other than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections
6 and 7 hereof.

 

(g)          The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular
and plural forms thereof. The terms “including,” “includes,” “include” and words of like import
shall be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.

 

(h)          This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any
signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed
signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such signature page were an original thereof.

 

    	-18-

    	 

    

 

(i)          Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver
all such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry
out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(j)          The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party. Notwithstanding anything to the contrary set forth in Section 10, terms
used in this Agreement but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing
Date in such other Transaction Documents unless otherwise consented to in writing by each Investor.

 

(k)          All
consents and other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise
specified in this Agreement, by the Required Holders.

 

(l)          The
obligations of each Investor under this Agreement and the other Transaction Documents are several and not joint with the obligations
of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor
under this Agreement or any other Transaction Document. Nothing contained herein or in any other Transaction Document, and no action
taken by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges
that the Investors do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or
create a presumption that the Investors are in any way acting in concert or as a group or entity with respect to such obligations
or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges that the Investors are
not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or the transactions
contemplated by this Agreement or any of the other the Transaction Documents. Each Investor shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction
Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained herein was solely in the control
of the Company, not the action or decision of any Investor, and was done solely for the convenience of the Company and not because
it was required or requested to do so by any Investor. It is expressly understood and agreed that each provision contained in this
Agreement and in each other Transaction Document is between the Company and an Investor, solely, and not between the Company and
the Investors collectively and not between and among Investors.

 

[Blank Space Prior to Signature Page]

    	-19-

    	 

    

 

IN WITNESS WHEREOF,
Seller and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as
of the date first written above.

  

	 	COMPANY:
	 	 
	 	SHARPLINK
    GAMING LTD.
	 	 	 
	 	 	 
	 	By:	 /s/
    Rob Phythian
	 	 	Name: Rob Phythian
	 	 	Title: Chief Executive Officer
	 	 	 
	 	SELLERS:
	 	 	 
	 	6T4 COMPANY
	 	 	 
	 	By:	/s/ Chris Carlson
	 	Name:	Chris Carlson
	 	Title:	President
	 	 	 
	 	/s/ Chris Carlson
	 	Chris Carlson

 

    	-20-

    	 

    

EXHIBIT A

 

SELLING STOCKHOLDERS

 

The Ordinary Shares
being offered by the selling stockholders are those shares issued or transferred to the selling stockholders or issuable to the
selling stockholders, in each case as partial consideration for the December 2021 sale of assets by 6t4 Company to the Company.
For additional information regarding the issuance of the Ordinary Shares, see “Asset Purchase Agreement” above. We
are registering the Ordinary Shares in order to permit the selling stockholders to offer the shares for resale from time to time.
Except for the ownership of the shares issued pursuant to the Asset Purchase Agreement, the selling stockholders have not had any
material relationship with us within the past three years [subject to verification]; except that Mr. Carlson has served as our
Vice President of Conversion since January 2022.

 

The table below lists
the selling stockholders and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities
Exchange Act of 1934, as amended, and the rules and regulations thereunder) of the Ordinary Shares held by each of the selling
stockholders. The second column lists the number of Ordinary Shares beneficially owned by the selling stockholders as of ________,
202__.

 

The third column
lists the Ordinary Shares being offered by this prospectus by the selling stockholders.

 

In accordance with
the terms of a registration rights agreement with the holders of the Ordinary Shares, this prospectus generally covers the resale
of the shares. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.

 

The selling stockholders
may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

 

	Name of Selling
Stockholder	 	Number of Ordinary Shares 
 Beneficially Owned Prior 
 to Offering	 	Maximum Number of Ordinary Shares to be Sold
 Pursuant to this Prospectus	 	Number of Ordinary Shares 
 Beneficially Owned After
 Offering

 

* Table to be completed based on information provided by
the Sellers and their assignees.

 

PLAN OF DISTRIBUTION

 

We are registering
the Ordinary Shares issued to the holders to permit the resale of these Ordinary Shares by the holders of such shares from time
to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholders of
the Ordinary Shares. We will bear all fees and expenses incident to our obligation to register the Ordinary Shares.

 

    	-21-

    	 

    

 

The selling stockholders
may sell all or a portion of the Ordinary Shares held by them and offered hereby from time to time directly or through one or more
underwriters, broker-dealers or agents. If the Ordinary Shares are sold through underwriters or broker-dealers, the selling stockholders
will be responsible for underwriting discounts or commissions or agent’s commissions. The Ordinary Shares may be sold in
one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at
the time of sale or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions,
pursuant to one or more of the following methods:

 

	 	●	on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;

 

	 	●	in the over-the-counter market;

 

	 	●	in transactions otherwise than on these exchanges or systems or in the over-the-counter market;

 

	 	●	through the writing or settlement of options, whether such options are listed on an options exchange or otherwise;

 

	 	●	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

	 	●	block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

 

	 	●	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

	 	●	an exchange distribution in accordance with the rules of the applicable exchange;

 

	 	●	privately negotiated transactions;

 

	 	●	short sales made after the date the Registration Statement is declared effective by the SEC;

 

	 	●	broker-dealers may agree with a selling securityholder to sell a specified number of such shares at a stipulated price per share;

 

	 	●	a combination of any such methods of sale; and

 

	 	●	any other method permitted pursuant to applicable law.

 

    	-22-

    	 

    

 

The selling stockholders
may also sell Ordinary Shares under Rule 144 promulgated under the Securities Act of 1933, as amended, if available, rather than
under this prospectus. In addition, the selling stockholders may transfer the Ordinary Shares by other means not described in this
prospectus. If the selling stockholders effect such transactions by selling Ordinary Shares to or through underwriters, broker-dealers
or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions
from the selling stockholders or commissions from purchasers of the Ordinary Shares for whom they may act as agent or to whom they
may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may
be in excess of those customary in the types of transactions involved). In connection with sales of the Ordinary Shares or otherwise,
the selling stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the
Ordinary Shares in the course of hedging in positions they assume. The selling stockholders may also sell Ordinary Shares short
and deliver Ordinary Shares covered by this prospectus to close out short positions and to return borrowed shares in connection
with such short sales. The selling stockholders may also loan or pledge Ordinary Shares to broker-dealers that in turn may sell
such shares.

 

The selling stockholders
may pledge or grant a security interest in some or all of the notes, warrants, Ordinary Shares owned by them and, if they default
in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Ordinary Shares from time
to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the
Securities Act amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors
in interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate the Ordinary Shares
in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.

 

To the extent required
by the Securities Act and the rules and regulations thereunder, the selling stockholders and any broker-dealer participating in
the distribution of the Ordinary Shares may be deemed to be “underwriters” within the meaning of the Securities Act,
and any commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions
or discounts under the Securities Act. At the time a particular offering of the Ordinary Shares is made, a prospectus supplement,
if required, will be distributed, which will set forth the aggregate amount of Ordinary Shares being offered and the terms of the
offering, including the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting
compensation from the selling stockholders and any discounts, commissions or concessions allowed or re-allowed or paid to broker-dealers.

 

Under the securities
laws of some states, the Ordinary Shares may be sold in such states only through registered or licensed brokers or dealers. In
addition, in some states the Ordinary Shares may not be sold unless such shares have been registered or qualified for sale in such
state or an exemption from registration or qualification is available and is complied with.

 

There can be no assurance
that any selling stockholder will sell any or all of the Ordinary Shares registered pursuant to the registration statement, of
which this prospectus forms a part.

 

    	-23-

    	 

    

 

The selling stockholders
and any other person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act
of 1934, as amended, and the rules and regulations thereunder, including, without limitation, to the extent applicable, Regulation
M of the Exchange Act, which may limit the timing of purchases and sales of any of the Ordinary Shares by the selling stockholders
and any other participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged
in the distribution of the Ordinary Shares to engage in market-making activities with respect to the Ordinary Shares. All of the
foregoing may affect the marketability of the Ordinary Shares and the ability of any person or entity to engage in market-making
activities with respect to the Ordinary Shares.

 

We will pay all expenses
of the registration of the Ordinary Shares pursuant to the registration rights agreement, estimated to be $[     ]
in total, including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state securities
or “blue sky” laws; provided, however, a selling stockholder will pay all underwriting discounts and selling commissions,
if any. We will indemnify the selling stockholders against liabilities, including some liabilities under the Securities Act in
accordance with the registration rights agreements or the selling stockholders will be entitled to contribution. We may be indemnified
by the selling stockholders against civil liabilities, including liabilities under the Securities Act that may arise from any written
information furnished to us by the selling stockholder specifically for use in this prospectus, in accordance with the related
registration rights agreements or we may be entitled to contribution.

 

Once sold under the
registration statement, of which this prospectus forms a part, the Ordinary Shares will be freely tradable in the hands of persons
other than our affiliates.

 

-24-EX-10.1

 Exhibit 10.1 

PURCHASE AGREEMENT 
 BY AND
BETWEEN 
 ATHENEX, INC. 
 AND

 IMMUNITYBIO, INC. 
 DATED
JANUARY 7, 2022 

 TABLE OF CONTENTS 

 

							
	 ARTICLE I DEFINITIONS
	  	 	2	 
	 1.1
	  	Definitions	  	 	2	 
	 1.2
	  	Other Defined Terms	  	 	5	 
		
	 ARTICLE II SALE AND TRANSFER OF ASSETS
	  	 	6	 
	 2.1
	  	Purchased Assets	  	 	6	 
	 2.2
	  	Excluded Assets	  	 	7	 
	 2.3
	  	Nonassignable Assets	  	 	7	 
	 2.4
	  	Liabilities	  	 	8	 
		
	 ARTICLE III PURCHASE PRICE
	  	 	8	 
	 3.1
	  	The Purchase Price	  	 	8	 
	 3.2
	  	Payment at Closing	  	 	9	 
	 3.3
	  	Allocation of Purchase Price	  	 	9	 
		
	 ARTICLE IV CLOSING
	  	 	9	 
	 4.1
	  	Closing	  	 	9	 
	 4.2
	  	Closing Actions and Deliveries	  	 	9	 
		
	 ARTICLE V REPRESENTATIONS AND WARRANTIES OF SELLER
	  	 	10	 
	 5.1
	  	Organization; Subsidiaries; Ownership	  	 	10	 
	 5.2
	  	Due Authorization; No Conflict	  	 	10	 
	 5.3
	  	Title to Assets; Condition; Sufficiency	  	 	11	 
	 5.4
	  	Leased Real Property	  	 	11	 
	 5.5
	  	Insurance	  	 	12	 
	 5.6
	  	Governmental Authorizations	  	 	12	 
	 5.7
	  	Compliance with Laws	  	 	12	 
	 5.8
	  	Environmental Matters	  	 	12	 
	 5.9
	  	Litigation	  	 	13	 
	 5.10
	  	Assigned Contracts	  	 	13	 
	 5.11
	  	Employees	  	 	13	 
	 5.12
	  	No Broker	  	 	14	 
	 5.13
	  	Employment Benefit Matters	  	 	14	 
	 5.14
	  	Benchmark Items	  	 	15	 
	 5.15
	  	DISCLAIMER OF OTHER REPRESENTATIONS AND WARRANTIES	  	 	15	 
		
	 ARTICLE VI REPRESENTATIONS AND WARRANTIES OF BUYER
	  	 	15	 
	 6.1
	  	Organization and Good Standing	  	 	15	 
	 6.2
	  	Due Authorization; No Conflict	  	 	15	 
	 6.3
	  	Litigation	  	 	16	 
	 6.4
	  	No Brokers	  	 	16	 
	 6.5
	  	Independent Investigation	  	 	16	 
	 6.6
	  	DISCLAIMER OF OTHER REPRESENTATIONS AND WARRANTIES	  	 	16	 

  
 i 

							
	 ARTICLE VII COVENANTS AND AGREEMENTS
	  	 	16	 
	 7.1
	  	Buyer’s Investigation	  	 	17	 
	 7.2
	  	Consents of Third Parties; Governmental Authorizations	  	 	17	 
	 7.3
	  	Actions Prior to Closing	  	 	17	 
	 7.4
	  	Notification of Certain Matters	  	 	18	 
	 7.5
	  	No Solicitation	  	 	18	 
	 7.6
	  	Satisfaction of Closing Conditions	  	 	19	 
	 7.7
	  	Further Assurances	  	 	19	 
	 7.8
	  	Transfer of Warranties	  	 	19	 
	 7.9
	  	Prorations	  	 	19	 
	 7.10
	  	Employees	  	 	19	 
	 7.11
	  	503B Agreement	  	 	20	 
	 7.12
	  	Facility Records	  	 	21	 
		
	 ARTICLE VIII CONDITIONS TO PERFORMANCE BY BUYER PARTIES
	  	 	21	 
	 8.1
	  	Representations and Warranties	  	 	21	 
	 8.2
	  	Covenants and Agreements	  	 	22	 
	 8.3
	  	Compliance Certificate	  	 	22	 
	 8.4
	  	Absence of Litigation	  	 	22	 
	 8.5
	  	Consents and Authorizations	  	 	22	 
	 8.6
	  	Other Closing Deliveries	  	 	22	 
		
	 ARTICLE IX CONDITIONS TO PERFORMANCE BY SELLER
	  	 	23	 
	 9.1
	  	Representations and Warranties	  	 	23	 
	 9.2
	  	Covenants and Agreements	  	 	23	 
	 9.3
	  	Compliance Certificate	  	 	23	 
	 9.4
	  	Absence of Litigation	  	 	23	 
	 9.5
	  	Consents and Authorizations	  	 	23	 
	 9.6
	  	Other Closing Deliveries	  	 	23	 
		
	 ARTICLE X TERMINATION
	  	 	24	 
	 10.1
	  	Termination	  	 	24	 
	 10.2
	  	Notice of Termination; Effect of Termination	  	 	24	 
	 10.3
	  	Return of Documentation	  	 	25	 
		
	 ARTICLE XI INDEMNIFICATION
	  	 	25	 
	 11.1
	  	Survival of Representations and Warranties	  	 	25	 
	 11.2
	  	Indemnification by Seller	  	 	25	 
	 11.3
	  	Indemnification by Buyer	  	 	26	 
	 11.4
	  	Indemnification Procedures	  	 	26	 
	 11.5
	  	Other Indemnification Provisions	  	 	28	 
	 11.6
	  	Insurance	  	 	28	 
	 11.7
	  	Cooperation, Access to Documents and Information	  	 	29	 
		
	 ARTICLE XII GENERAL PROVISIONS
	  	 	29	 
	 12.1
	  	Expenses; Transfer Taxes	  	 	29	 

  
 ii 

							
	 12.2
	  	Entire Agreement; No Third Party Beneficiaries; Amendment	  	 	29	 
	 12.3
	  	Severability	  	 	29	 
	 12.4
	  	Waiver	  	 	29	 
	 12.5
	  	Public Announcements	  	 	30	 
	 12.6
	  	Successors and Assigns	  	 	30	 
	 12.7
	  	Specific Performance	  	 	30	 
	 12.8
	  	Notice	  	 	30	 
	 12.9
	  	Counterparts; Facsimile Signatures	  	 	31	 
	 12.10
	  	Governing Law	  	 	31	 
	 12.11
	  	Jurisdiction	  	 	32	 
	 12.12
	  	Interpretation	  	 	32	 
			
	 SCHEDULES
	  		  	 	II	 

  
 iii 

 PURCHASE AGREEMENT 

THIS PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 7, 2022, by and between
ATHENEX, INC., a Delaware corporation (“Seller”), and IMMUNITYBIO, INC., a Delaware corporation (“Buyer”). Buyer and Seller are sometimes referred to herein individually as a “Party”
and collectively as the “Parties.” 
 RECITALS 

A. Seller (formerly known as Kinex Pharmaceuticals, Inc) and Fort Schuyler Management Corporation (“FSMC”) entered into the
Agreement for Medical Technology Research, Development, Innovation, and Commercialization Alliance Agreement dated May 1, 2015, as amended by (i) the First Amendment to the Agreement for Medical Technology Research, Development,
Innovation, and Commercialization Alliance Agreement dated July 21, 2015, and (ii) the Second Amendment to the Agreement for Medical Technology Research, Development, Innovation, and Commercialization Alliance Agreement dated June 22,
2016 (collectively, the “Alliance Agreement”) which provided for, among other things, (i) the design and construction of a cGMP ISO Class 5 high potency pharmaceutical manufacturing facility located at 3805 Lakeshore Drive
East, Dunkirk, New York (the “Manufacturing Facility”), to be owned by FSMC and leased to Seller, and (ii) certain commitments by Seller regarding hiring and investment at the Manufacturing Facility. 

B. Following completion of the construction of the Manufacturing Facility, Seller and FSMC entered into the Fort Schuyler Management
Corporation Lease, dated as of October 1, 2021 (the “Lease Agreement”), pursuant to which Seller leases from FSMC certain space encompassing approximately 409,000 square feet in the Manufacturing Facility and consisting of
approximately 33.6 acres of real property, as more particularly described in the Lease Agreement (collectively, the “Leased Real Property”) and certain manufacturing equipment described in (or to be described in) the Lease Agreement
(collectively, the “Leased Manufacturing Equipment”). 
 C. New York State Urban Development Corporation d/b/a Empire State
Development Agreement (“ESD”) agreed to fund up to $200,000,000 for the design and construction of the Manufacturing Facility, pursuant to a Capital Grant Agreement, dated as of September 4, 2017, between ESD and Seller, as
amended by the Capital Grant Agreement Amendment dated as of July 23, 2019. 
 D. Seller entered into various agreements with the
County of Chautauqua Industrial Development Agency (“CCIDA”) with respect to the Manufacturing Facility, pursuant to which the CCIDA provides Seller with certain tax benefits, in exchange for certain payments by Seller to CCIDA and
certain commitments by Seller regarding hiring and investment at the Manufacturing Facility and, in connection therewith, Seller and CCIDA entered into a lease - leaseback arrangement whereby Seller subleases the Manufacturing Facility to CCIDA, and
CCIDA subleases the Manufacturing Facility back to Athenex. 
 E. Seller desires to sell, assign, and transfer to Buyer, and Buyer desires
to acquire from Seller, certain assets and rights of Seller, and Buyer is willing to assume certain liabilities and obligations of Seller, relating to the Manufacturing Facility, upon the terms and subject to the conditions hereinafter set forth.

 NOW, THEREFORE, in consideration of the premises and of the mutual covenants hereinafter set
forth, the Parties hereby agree as follows: 
 ARTICLE I 

Definitions. 
 1.1
Definitions. The following terms shall have the meanings ascribed to such terms in this Section 1.1. 

“Affiliate” means, with respect to a specified Person, a Person that directly, or indirectly through one or more
intermediaries, controls, is controlled by or is under common control with, the specified Person. For purposes of this definition, the term “control” (including the terms “controlling,” “controlled by” and “under
common control with”) means (a) the possession, directly or indirectly, of the power to vote more that 50% of the securities or other equity interests of a Person having ordinary voting power, or (b) the possession, directly or
indirectly, of the power to direct or cause the direction of the management policies of a Person, by contract or otherwise. 

“Business Day” means a day other than a Saturday, a Sunday or a day on which commercial banks are authorized or required to
be closed in the State of New York. 
 “CCIDA Lease Agreements” means, collectively, (i) the Company Lease Agreement,
dated as of October 1, 2021, between Seller and CCIDA, and (ii) the Agency Lease Agreement, dated as of October 1, 2021, between CCIDA and Athenex. 

“Closing Date” means the date on which the Closing occurs. 

“Contract” means, with respect to any Person, any contract, agreement, deed, mortgage, lease or license, whether written or
oral, which pertains to such Person or any material assets of such Person. 
 “Environmental Claim” means any action, suit,
claim, investigation or other legal proceeding by any Person alleging liability of whatever kind or nature (including liability or responsibility for the costs of enforcement proceedings, investigations, cleanup, governmental response, removal or
remediation, natural resources damages, property damages, personal injuries, medical monitoring, penalties, contribution, indemnification and injunctive relief) arising out of, based on or resulting from: (a) the Environmental Release of, or
exposure to, any Hazardous Substances; or (b) any actual or alleged non-compliance with any Environmental Law or term or condition of any Environmental Permit. 

“Environmental Law” means all Laws relating to the protection of the environment and occupational health and safety. 

“Environmental Matters” means collectively Environmental Claims, Environmental Laws, Environmental Notices, Environmental
Release and/or Environmental Permits. 
 “Environmental Notice” means any written directive, notice of violation or
infraction, or notice respecting any Environmental Claim relating to actual or alleged non-compliance with any Environmental Law or any term or condition of any Environmental Permit. 

  
 2 

 “Environmental Permit” means any Governmental Authorizations required
pursuant to Environmental Laws. 
 “Environmental Release” means any actual or threatened release, spilling, leaking,
pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, abandonment, disposing or allowing to escape or migrate into or through the environment (including, without limitation, ambient air (indoor or outdoor),
surface water, groundwater, land surface or subsurface strata or within any building, structure, facility or fixture). 
 “General
Enforceability Exceptions” means general principles of equity and by bankruptcy, insolvency or similar Laws and general equitable principles affecting the rights of creditors generally. 

“Governmental Authority” means any domestic or foreign federal, state or local government, or political subdivision thereof,
or any authority, agency or commission entitled to exercise any administrative, executive, judicial, legislative, police, regulatory or taxing authority or power, any court or tribunal (or any department, bureau or division thereof), or any
arbitrator or arbitral body. 
 “Governmental Authorization” means any approval, consent, ratification, waiver, license,
permit, registration or other authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Authority or pursuant to any Law, including without limitation, any bond, certificate of authority,
accreditation, qualification, license, franchise, permit, order, registration, variance or privilege. 
 “Governmental
Order” means any order, writ, judgment, injunction, decree, stipulation, ruling, determination or award entered by or with any Governmental Authority. 

“Hazardous Substance” means (a) any petroleum or petroleum products, radioactive materials, asbestos in any form that is
or could become friable, urea formaldehyde foam insulation, polychlorinated biphenyls, and (b) any chemicals, materials, substances or wastes defined as or included in the definition of “hazardous substances,” “hazardous
waste,” “hazardous materials,” “extremely hazardous substances,” “restricted hazardous waste,” “toxic substances,” “toxic pollutants,” “contaminants” or “pollutants” under
any applicable Environmental Law. 
 “Knowledge” means (i) with respect to Seller, the actual knowledge, after
reasonable inquiry, of the Persons listed for Seller on Schedule 1.1, and (ii) with respect to Buyer, the actual knowledge, after reasonable inquiry, of the Persons listed for Buyer on Schedule 1.1. 

“Law” means any foreign, federal, state or local law, treaty, constitution, statute, ordinance, common law, ruling or
regulation, or any Governmental Order, or any license, franchise, permit or similar right granted under any of the foregoing, or any similar provision having the force or effect of law. 

“Liability” means, with respect to any Person, any liability or obligation of such Person whether known or unknown, whether
asserted or unasserted, whether determined, determinable or otherwise, whether absolute or contingent, whether accrued or unaccrued, whether liquidated or unliquidated and whether due or to become due. 

  
 3 

 “Lien” means any mortgage, pledge, hypothecation, security interest,
encumbrance, adverse claim or interest, easement, covenant, encroachment, title retention agreement, title defect, voting trust agreement, transfer restriction, community property interest, deed of trust, lease, proxy, lien, preemptive right, right
of first offer or refusal or similar right or encumbrance. 
 “Material Environmental Liability” means each individual
liability, claim or cause of action due to Environmental Matters in excess of $50,000. 
 “Organizational Documents” means,
with respect to any Person (other than an individual), the certificate or articles of incorporation or organization, certificate of limited partnership and any joint venture, limited liability company, operating, voting or partnership agreement, by-laws, or similar documents, instruments or agreements relating to the organization or governance of such Person, in each case, as amended or supplemented. 

“Permitted Lien” means any (a) Liens for taxes not yet due and payable; (b) Liens that secure only Assumed
Liabilities or that constitute Assumed Liabilities; (c) Liens to secure landlords, sub landlords, licensors or sub licensors under real estate leases or rental agreements, (d) Liens in favor of lessors under capitalized leases but only to
the extent that such Liens encumber the equipment or other property leased pursuant thereto, (e) zoning, entitlement, building and other similar restrictions which would be shown by a current and accurate survey and are not violated by the
current conduct of the business, or any local ordinances, codes, or regulations, (f) easements, covenants, rights of way, or other encumbrances, or restrictions, encroachments or matters, if any, that are of record or that would be shown on a
current and accurate survey of the Leased Real Property, which do not materially interfere with the use and enjoyment of the Leased Real Property. 

“Person” means any individual or corporation, association, partnership, limited liability company, joint venture, joint stock
or other company, business trust, trust, organization, Governmental Authority or other entity of any kind. 
 “Proceeding”
means any litigation, action, suit, mediation, arbitration, assessment, investigation, hearing, grievance or similar proceeding (in each case, whether civil, criminal, administrative or investigative) initiated, commenced, conducted, heard, or
pending by or before any Governmental Authority, arbitrator or mediator. 
 “SEC” means the U.S. Securities and Exchange
Commission. 
 “Tax” or “Taxes” means any tax, charge, deficiency, duty, fee, levy, toll or other amount
(including, without limitation, any net income, gross income, profits, gross receipts, escheat, excise, property, sales, ad valorem, withholding, social security, retirement, excise, employment, unemployment, minimum, alternative, add-on minimum, estimated, severance, stamp, occupation, environmental, premium, capital stock, disability, windfall profits, use, service, net worth, payroll, franchise, license, gains, customs, transfer,
recording, registration or other tax) assessed or otherwise imposed by any Governmental Authority or under applicable law, together with any interest, penalties or any other additions or increases. 

“Transaction Documents” means this Agreement, the Bill of Sale, the Contract Assignments, and all other written agreements,
documents and certificates listed as closing deliveries in Article VIII or Article IX, that are executed and delivered at Closing. 

  
 4 

 1.2 Other Defined Terms. The following terms have the meanings defined for
such terms in the Sections set forth below: 
  

			
	 503B Agreement
	  	 Section 7.11

		
	 Additional Facility Costs
	  	 Section 3.1

		
	 Agreement
	  	 Preamble

		
	 AIA Agreement
	  	 Section 7.2

		
	 Alliance Agreement
	  	 Recitals

		
	 Allocation Schedule
	  	 Section 3.3

		
	 Architect
	  	 Section 7.3

		
	 Assigned Contracts
	  	 Section 2.1(d)

		
	 Assumed Liabilities
	  	 Section 2.4(a)

		
	 Benefit Plan
	  	 Section 5.13(a)

		
	 Bill of Sale
	  	 Section 8.6(a)

		
	 Buyer
	  	 Preamble

		
	 Buyer Indemnitee
	  	 Section 11.2

		
	 Charges
	  	 Section 7.9

		
	 Claim
	  	 Section 11.4(a)

		
	 Closing
	  	 Section 4.1

		
	 Code
	  	 Section 5.13(b)

		
	 Contract Assignments
	  	 Section 8.6(b)

		
	 Deemed Acceptance
	  	 Section 11.4(a)

		
	 Design-Builder
	  	 Section 7.2

		
	 Dispute Notice
	  	 Section 11.4(a)

		
	 ESD
	  	 Recitals

		
	 Environmental Documents
	  	 Section 5.8(b)

		
	 ERISA
	  	 Section 5.13(b)

		
	 Excluded Assets
	  	 Section 2.2

		
	 Facility Costs
	  	 Section 3.1

		
	 Facility Employee
	  	 Section 5.11(a)

		
	 Facility Governmental Authorizations
	  	 Section 5.6

		
	 Facility Records
	  	 Section 2.1(h)

		
	 FSMC
	  	 Recitals

		
	 Fundamental Representations
	  	 Section 11.1

  
 5 

			
	 Indemnified Party
	  	 Section 11.4(a)

		
	 Indemnifying Party
	  	 Section 11.4(a)

		
	 Insurance Policy
	  	 Section 5.5

		
	 Lease Agreement
	  	 Recitals

		
	 Leased Manufacturing Equipment
	  	 Recitals

		
	 Leased Real Property
	  	 Recitals

		
	 Losses
	  	 Section 11.2

		
	 Manufacturing Facility
	  	 Recitals

		
	 Material Consents
	  	 Section 8.5

		
	 Non-assignable Asset
	  	 Section 2.3

		
	 Owned Personal Property
	  	 Section 2.1(b)

		
	 Party
	  	 Preamble

		
	 Purchase Price
	  	 Section 3.1

		
	 Purchased Assets
	  	 Section 2.1

		
	 Retained Liabilities
	  	 Section 2.4(b)

		
	 Seller
	  	 Preamble

		
	 Seller Indemnitee
	  	 Section 11.3

		
	 Seller Required Consents
	  	 Section 5.2(c)

		
	 Third Party Claim
	  	 Section 11.4(b)

		
	 Threshold
	  	 Section 11.5(b)

		
	 Transaction Proposal
	  	 Section 7.5

		
	 Transferred Employee
	  	 Section 7.10(a)

		
	 Transfer Taxes
	  	 Section 12.1

 ARTICLE II 

Sale and Transfer of Assets. 

2.1 Purchased Assets. Upon the terms and subject to the conditions of this Agreement, at the Closing, Seller shall sell, transfer,
assign, convey and deliver to Buyer, and Buyer shall purchase from Seller, free and clear of all Liens other than Permitted Liens, all of the right, title and interest that Seller possesses in and to all of the following assets and properties
(collectively, the “Purchased Assets”): 
 (a) Seller’s leasehold interest in the Leased Manufacturing Equipment (as
more particularly described on Schedule 2.1(a), which shall be updated by the Parties within three (3) Business Days prior to the Closing) and the Leased Real Property, pursuant to the Lease Agreement; 

  
 6 

 (b) all tangible personal property, including computer hardware, manufacturing equipment,
office equipment, accessories, machinery, furniture, and fixtures owned by Seller and located at the Manufacturing Facility (collectively, the “Owned Personal Property”), as more particularly set forth on Schedule 2.1(b)
(which shall be updated by the Parties within three (3) Business Days prior to the Closing); 
 (c) all of Seller’s inventories
and supplies located at the Manufacturing Facility on the Closing Date other than the raw materials and product inventory for 503B products; 

(d) all of Seller’s rights under the Contracts (collectively, the “Assigned Contracts”) identified on Schedule
2.1(d) (which shall be updated by the Parties within three (3) Business Days prior to the Closing), subject to the provisions of Section 2.4(c)); 

(e) all of Seller’s rights relating to deposits and prepayments with respect to purchase orders or other Contracts included in the
Assigned Contracts, as more particularly set forth on Schedule 2.1(e) (which shall be updated by the Parties within three (3) Business Days prior to the Closing); 

(f) the Facility Governmental Authorizations, to the extent assignable; 

(g) all warranties (express and implied) that continue in effect with respect to the Manufacturing Facility or any Purchased Asset (including,
without limitation, warranties provided for under any Assigned Contract), to the extent assignable; and 
 (h) originals, or where not
available, copies, of material documents and records of Seller, in Seller’s possession or control, relating specifically and solely to the Manufacturing Facility, the Purchased Assets, or the Assigned Contracts (the “Facility
Records”). 
 2.2 Excluded Assets. Except as specifically included in the Purchased Assets described in Section 2.1,
Buyer shall not acquire any other assets or properties (real, personal or mixed, tangible or intangible), of any kind or description of Seller or any Affiliate of Seller (collectively, the “Excluded Assets”). 

2.3 Nonassignable Assets. Nothing in this Agreement, the Bill of Sale or the Contract Assignments or the consummation of the
transactions contemplated hereby or thereby shall be construed as an attempt or agreement to assign or transfer any Purchased Asset (including any Assigned Contract or Facility Governmental Authorization) to Buyer which by its terms or by Law is not
assignable or transferable without a consent or is cancelable by a third party in the event of an assignment or transfer (a “Nonassignable Asset”), unless and until such consent shall have been obtained or Law satisfied. Seller and
Buyer shall obtain as expeditiously as possible any consent that may be required and satisfy any Law necessary to the assignment or transfer of a Nonassignable Asset to Buyer, and Seller shall take all such actions as may be necessary to effect the
assignment or transfer of the Nonassignable Asset. Unless and until any such consent that may be required is obtained or Law satisfied, Seller shall establish an arrangement reasonably satisfactory to Buyer under which Buyer would obtain the claims,
rights and benefits and assume the corresponding liabilities and obligations under such Nonassignable Asset (including by means of any subcontracting, sublicensing or subleasing arrangement) or under which Seller would enforce for the benefit of
Buyer, with Buyer assuming and agreeing to pay Seller’s obligations and reasonable expenses, any and all claims, rights and benefits of Seller against a third party thereto; 

  
 7 

 
provided, that in no event shall Buyer be required to enter into any such arrangement with respect to any Nonassignable Asset for which a required consent is necessary or be required to
incur any unreimbursed expenses in connection with such arrangement. Seller shall promptly pay over to Buyer all payments received by such Seller in respect of all Nonassignable Assets. If and when the applicable consents or approvals, the absence
of which caused the deferral of transfer of any Nonassignable Asset pursuant to this Section, are obtained, the transfer of the applicable Nonassignable Asset to Buyer shall automatically and without further action be effected in accordance with the
terms of this Agreement. 
 2.4 Liabilities. 

(a) Subject to the terms and conditions of this Agreement, at the Closing, Buyer shall assume and agree to perform, pursuant to the Bill of
Sale and the Contract Assignments, as applicable, only the Liabilities of Seller under the Assigned Contracts arising, accruing, or required to be performed after the Closing Date (collectively, the “Assumed Liabilities”). 

(b) Except for the Assumed Liabilities described in Section 2.4(a), Buyer shall not assume, nor shall it agree to pay, perform or
discharge, any Liability of Seller or any Affiliate of Seller (collectively, the “Retained Liabilities”). 
 (c) The
Parties acknowledge that the Alliance Agreement includes provisions relating to Seller’s corporate headquarters in Buffalo, New York, in addition to those relating to the Manufacturing Facility. Notwithstanding anything in this Agreement to the
contrary, Seller shall retain all rights, liabilities, and obligations under the Alliance Agreement that relate specifically to Seller’s corporate headquarters located in the Coventus Building, 1001 Main Street, Buffalo, New York (none of which
shall constitute part of the Assigned Contracts and all of which shall constitute Excluded Assets and Retained Liabilities, as applicable). In connection with the assignment of the Alliance Agreement and the request for FSMC’s consent to such
assignment, Seller and Buyer shall negotiate with FSMC to amend, modify, or restate, in whole or in part, the Alliance Agreement as necessary and appropriate to bifurcate and allocate, as between Seller and Buyer, the respective rights, liabilities,
and obligations thereunder between Seller (with respect to its corporate headquarters) and Buyer (with respect to the Manufacturing Facility). 

ARTICLE III 
 Purchase
Price. 
 3.1 The Purchase Price. The aggregate purchase price (the “Purchase Price”) to be paid by Buyer for
the Purchased Assets shall be an amount equal to (a) $38,165,366 (which for the avoidance of doubt reflects Facility Costs incurred to date inclusive of Seller’s current accounts payable) plus (b) the aggregate amount of Facility
Costs incurred by Seller between December 18, 2021 and the Closing Date (the “Additional Facility Costs”), as agreed upon by Buyer and Seller prior to the Closing, provided, however, that the Purchase Price shall not exceed
$40,000,000. Within three (3) Business Days prior to the Closing, Seller shall deliver to Buyer for its review and approval Seller’s calculation of the Additional Facility Costs (which calculation shall be consistent with Seller’s
prior calculations of Facility Costs used for purposes of determining the Purchase Price) and, if Buyer disputes any amounts in such calculation, Buyer and Seller shall negotiate in good faith to resolve such dispute prior to the Closing. The
Parties acknowledge that 

  
 8 

 
the Purchase Price shall reflect the aggregate amount of costs incurred by Seller prior to the Closing with respect to the design, development, construction, staffing, equipping, and operation of
the Manufacturing Facility and the satisfaction of its obligations for the Manufacturing Facility under certain Assigned Contracts (collectively, “Facility Costs”). The Purchase Price shall be allocated among the Purchased Assets as
set forth in Section 3.3, and shall be payable to Seller in accordance with the provisions of Section 3.2. 
 3.2 Payment at
Closing. Subject to the terms and conditions of this Agreement, at Closing, Buyer shall pay the Purchase Price to Seller by wire transfer of immediately available funds to an account designated in writing by Seller at least three
(3) Business Days prior to Closing. 
 3.3 Allocation of Purchase Price. The Parties agree that the Purchase Price shall be
allocated among the Purchased Assets for all purposes (including tax and financial accounting) as shown on the allocation schedule determined pursuant to this Section (the “Allocation Schedule”). Buyer shall prepare and deliver to
Seller a draft of the Allocation Schedule at least five (5) Business Days prior to the Closing. If, prior to the Closing, Seller notifies Buyer in writing that Seller objects to one or more items reflected in the Allocation Schedule, Seller and
Buyer shall negotiate in good faith to resolve such dispute prior to the Closing Date. If Seller fails to deliver such objection prior to the Closing, the Allocation Schedule provided by Buyer shall be final and binding for purposes of this Section.
Seller and Buyer and their respective Affiliates shall report, act and file all tax returns in all respects and for all purposes consistent with the Allocation Schedule. No Party shall take any position in any tax matter (whether in audit, tax
returns, or otherwise with any Governmental Authority) that is inconsistent with the Allocation Schedule unless required to do so by applicable Law. 

ARTICLE IV 
 Closing. 

4.1 Closing. The closing of the transactions contemplated hereby (the “Closing”) shall take place at such place as is
agreed in writing by Buyer and Seller, or via electronic transmittal of documents, on a date designated by Buyer not later than five (5) Business Days after the date that the conditions set forth in Article VIII and Article IX have been
satisfied or waived (other than conditions that by their terms are to be satisfied at Closing, but subject to the satisfaction or waiver of such conditions), or on such other date or at such other place or time as is mutually agreed upon by Buyer
and Seller. For financial accounting and tax purposes, to the extent permitted by Law, the Closing shall be deemed to have become effective as of 11:59 p.m. on the Closing Date. 

4.2 Closing Actions and Deliveries. All actions to be taken and all documents to be executed and delivered in connection with the
consummation of the transactions provided for herein shall be in form and substance agreed upon by the Parties and their respective counsel. All actions to be taken and all documents to be executed and delivered by the Parties at the Closing shall
be deemed to have been taken and executed simultaneously, and no action shall be deemed taken nor any document executed and delivered until all have been taken, executed and delivered. 

  
 9 

 ARTICLE V 

Representations and Warranties of Seller. 

Seller makes the following representations and warranties to Buyer as of the date hereof and as of the Closing Date (except to the extent made
only as of a specified date, in which case as of such date), which representations and warranties are supplemented and qualified by the disclosures contained in the Schedules attached hereto that contains references to the representations and
warranties to which the disclosures contained therein relate. 
 5.1 Organization; Subsidiaries; Ownership. Seller is a
corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has the full right, power and authority to own, lease and operate all of its properties and assets and carry out its business as it is
presently conducted. 
 5.2 Due Authorization; No Conflict. 

(a) Seller has the corporate power and authority to execute and deliver this Agreement and all other Transaction Documents to which it is a
party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution, delivery and performance by Seller of this Agreement and all other Transaction Documents to which it is a
party have been duly authorized by all necessary corporate action. 
 (b) This Agreement has been duly executed and delivered by Seller.
This Agreement, and all other Transaction Documents executed or to be executed by Seller in connection herewith, constitute or, when executed and delivered, shall constitute a legal, valid and binding contract of Seller, enforceable against Seller
in accordance with its terms, except as enforcement may be limited by General Enforceability Exceptions. 
 (c) Except for the consents,
approvals and authorizations set forth in Schedule 5.2(c) (collectively, the “Seller Required Consents”), the execution and delivery by Seller of this Agreement and the Transaction Documents to which Seller is a party, the
performance by Seller of its obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby, shall not (with or without notice or lapse of time): (i) violate, conflict with, result in a breach of the
terms or conditions of, or constitute a default, an event of default or an event creating rights of acceleration, termination or cancellation or a loss of rights under, (A) any Assigned Contract, (B) any other Contract to which Seller is a
party or any of the Purchased Assets is subject or by which Seller is bound, or (C) any Law, Governmental Authorization or Governmental Order applicable to Seller, the Purchased Assets, or the Assumed Liabilities; (ii) contravene the
Organizational Documents of Seller; (iii) require Seller to make any declaration, filing or registration with, or provide any notice to, any Governmental Authority or obtain any Governmental Authorization, (iv) require any consent,
approval or authorization of, declaration, filing or registration with, or notice to, any other Person; or (v) result in the creation or imposition of any Lien (other than Permitted Liens) upon any of the Purchased Assets. 

  
 10 

 5.3 Title to Assets; Condition; Sufficiency. 

(a) Except as set forth on Schedule 5.3(a), Seller has (and shall transfer to Buyer at the Closing) good title to all of the Owned
Personal Property, free and clear of all Liens, except Permitted Liens. 
 (b) The Owned Personal Property and the Leased Manufacturing
Equipment are in good working order, condition and repair, reasonable wear and tear excepted. 
 5.4 Leased Real Property. 

(a) Schedule 5.4(a) contains a true, complete and accurate description of the Leased Real Property. Except for the CCIDA Lease
Agreements, there are no subleases, licenses, concessions, occupancy agreements or other Contracts granting to any other Person the right of use or occupancy of the Leased Real Property and there is no Person (other than Seller) in possession of the
Leased Real Property. Seller has made available to Buyer to Buyer true and correct copies of the Lease Agreement and the CCIDA Lease Agreements, and they have not been further amended. Seller has (and shall transfer to Buyer at Closing) a leasehold
interest in the Leased Real Property, free and clear of all Liens, except Permitted Liens. 
 (b) Seller presently enjoys peaceful and
undisturbed possession of the Leased Real Property. There is no pending or, to the Knowledge of Seller, threatened eminent domain taking affecting any portion of the Leased Real Property which shall interfere with the operation of the Leased Real
Property. Except as set forth on Schedule 5.4(b), to the Knowledge of Seller, no event or condition currently exists which would create a legal or other impediment to the use of the Leased Real Property as currently used (or as intended to be
used under the Lease Agreement), or would increase the additional charges or other sums payable by the tenant under the Lease Agreement (including, without limitation, any pending tax reassessment or other special assessment affecting the Leased
Real Property). 
 (c) Seller has not received written notice from any Governmental Authority of any violations of any Law affecting any
portion of the Leased Real Property. 
 (d) Each of the Lease Agreement and CCIDA Lease Agreements is in full force and effect and is
binding and enforceable against Seller and, to the Knowledge of Seller, each of the other parties thereto, in accordance with its terms, except as enforcement may be limited by General Enforceability Exceptions. There has not been under the Lease
Agreement or any CCIDA Lease Agreement any material breach or default by Seller or, to the Knowledge of Seller, by any other party thereto, nor any event which, after notice or lapse of time, or both, would constitute any such material breach or
default by Seller or, to the Knowledge of Seller, by any other party thereto. Seller has not received any written claim from any other party to the Lease Agreement or any CCIDA Lease Agreement that Seller has breached in any material respect any
obligations to be performed by it thereunder, or is otherwise in default or delinquent in performance thereunder. 
 (e) All contractors who
performed and completed work at the Leased Real Property pursuant to the AIA Agreement have been paid in full, except as set forth on Schedule 5.4(e). 

  
 11 

 (f) Except as set forth in the letter described on Schedule 5.10, the Manufacturing
Facility is in good condition and repair, ordinary wear and tear excepted. 
 (g) Neither the whole nor any material portion of the Leased
Real Property has been damaged or destroyed by fire or other casualty within the prior twelve (12) months. 
 (h) The Certificate of
Occupancy for the Manufacturing Facility covers the entire Manufacturing Facility. Seller has used the Manufacturing Facility in compliance with such Certificate of Occupancy. 

5.5 Insurance. Schedule 5.5 sets forth a description of the current insurance policies pertaining to the Leased Real Property
maintained by Seller (each, an “Insurance Policy”). The description includes for each Insurance Policy the type of policy, policy number, name of insurer and expiration date. Seller has made available to Buyer true, accurate and
complete copies of all such Insurance Policies, in each case, as amended or otherwise modified and in effect with respect to Seller. 
 5.6
Governmental Authorizations. Schedule 5.6 sets forth a list of all material Governmental Authorizations that Seller currently holds with respect to its lease, operation, and use of the Manufacturing Facility (the “Facility
Governmental Authorizations”). Seller has not been a party to or subject to any Proceeding seeking to revoke, suspend or otherwise limit any Facility Governmental Authorization, and Seller has not received any written notice of any such
Proceeding or any threat thereof. Each of the Facility Governmental Authorizations is valid and in full force and effect, and Seller is in compliance in all material respects with the terms of all of its Facility Governmental Authorizations. 

5.7 Compliance with Laws. Seller is in compliance in all material respects with all applicable Laws relating to the lease, operation,
or use of the Manufacturing Facility. Seller has not received any written notice from any Governmental Authority of any violation of any Law relating to the lease, operation, or use of the Manufacturing Facility. 

5.8 Environmental Matters. 

(a) Except as set forth on Schedule 5.8(a), (i) Seller has conducted its operations at the Leased Real Property in compliance with all
applicable Environmental Laws and Environmental Permits, (ii) Seller has obtained, and has maintained in full force and effect, all Environmental Permits required for its operations at the Leased Real Property, (iii) Seller has managed and
handled Hazardous Substances on the Leased Real Property in compliance with applicable Environmental Laws and Environmental Permits, (iv) there are no past, pending or, to the Knowledge of Seller, threatened claims or Proceedings pursuant to
Environmental Laws against Seller, any of the Purchased Assets or, to the Knowledge of Seller, the Leased Real Property, and (v) to the Knowledge of Seller, there are no Hazardous Substance conditions at the Leased Real Property (x) in
violation of applicable Environmental Laws or Environmental Permits or (y) for which investigation, remediation or other corrective action is required under Environmental Laws or Environmental Permits. 

(b) Seller has provided or made available to Buyer all environmental reports in the possession or control of Seller (as more particularly set
forth on Schedule 5.8(b)), all Environmental Permits, and other relevant, material environmental documentation 

  
 12 

 
(“Environmental Documents”) pertaining to the Leased Real Property in the possession or control of Seller. 

(c) The representations and warranties in this Section 5.8 are Seller’s sole representations and warranties with respect to all
Environmental Matters, including matters involving Hazardous Substances. 
 5.9 Litigation. Except as set forth in Schedule
5.9, (a) there is no Proceeding pending or, to the Knowledge of Seller, threatened (i) against Seller or affecting the Purchased Assets or the Manufacturing Facility or (ii) which seeks to prohibit, restrict or delay consummation
of the transactions contemplated by this Agreement or any of the conditions to consummation of such transactions and, (b) there is no Governmental Order outstanding or, to the Knowledge of Seller, threatened (i) against Seller or affecting
the Purchased Assets or the Manufacturing Facility, or (ii) which seeks to prohibit, restrict or delay consummation of the transactions contemplated by this Agreement or any of the conditions to consummation of such transactions. 

5.10 Assigned Contracts. Except as set forth on Schedule 2.1(d), Seller has made available to Buyer true and correct copies of
each of the Assigned Contracts. Each of Assigned Contracts is in full force and effect and is binding and enforceable against Seller and, to the Knowledge of Seller, each of the other parties thereto, in accordance with its terms, except as
enforcement may be limited by General Enforceability Exceptions. Except as set forth on Schedule 5.10, there has not been under any such Assigned Contract any material breach or default by Seller or, to the Knowledge of Seller, by any other
party thereto, nor any event which, after notice or lapse of time, or both, would constitute any such material breach or default by Seller or, to the Knowledge of Seller, by any other party thereto. Seller has not received any written claim from any
other party to any Assigned Contract that Seller has breached in any material respect any obligations to be performed by it thereunder, or is otherwise in default or delinquent in performance thereunder. 

5.11 Employees. 
 (a)
Seller has made available to Buyer a true and complete list setting forth the name, position, salary or wage rate, commission status, date of hire, full- or part-time status, active or leave status and “exempt” or “non-exempt” status, for each employee or individual service provider of Seller who is assigned to work primarily at the Manufacturing Facility as of the date hereof (collectively, the “Facility
Employees”), including any individual absent due to short-term disability, family or medical leave, military leave or other approved absence. Seller is not party to any management, employment, consulting or other agreements or
understandings with any Facility Employee providing for employment for a defined period of time or on an other than “at-will” basis. 

(b) Seller is not a party to, or bound by, any collective bargaining or other agreement with a labor organization representing any Facility
Employees. There has not been, nor, to the Knowledge of Seller, has there been any threat of, any strike, slowdown, work stoppage, lockout, labor organizing, concerted refusal to work overtime or other similar labor activity or dispute affecting
Seller in respect of the Manufacturing Facility. 

  
 13 

 (c) Except as set forth in Schedule 5.11(c) there are no Proceedings against Seller
pending or, to the Knowledge of Seller, threatened to be brought or filed, by or with any Governmental Authority or arbitrator in connection with the employment of any current or former Facility Employee, including, without limitation, any claim
relating to unfair labor practices, employment discrimination, harassment, retaliation, equal pay or any other employment related matter arising under applicable Laws. 

(d) Seller is in compliance in all material respects with all applicable Laws pertaining to employment and employment practices (including all
Laws relating to terms and conditions of employment, wages, hours, overtime compensation, child labor, hiring, promotion and termination of Facility Employees, working conditions, meal and break periods, privacy, collective bargaining, workers’
compensation, occupational safety and health, equal employment opportunity, fair employment practices, employment discrimination, harassment, retaliation, reasonable accommodation, disability rights or benefits, immigration, leaves of absence and
unemployment insurance), to the extent they relate to Facility Employees. All Facility Employees classified as exempt under the Fair Labor Standards Act and state and local wage and hour Laws are properly classified. Seller has not received any
written notice alleging that it has failed to comply with any such Laws as it relates to the Facility Employees. There are no pending or, to the Knowledge of Seller, threatened Proceedings regarding any alleged misclassification of Facility
Employees as independent contractors. 
 (e) Assuming Buyer’s compliance with Section 7.10, Seller has not taken any action that
could constitute a “mass layoff” or “plant closing” within the meaning of the Worker Adjustment and Retraining Notification (“WARN Act”) or similar state Law or could otherwise trigger any notice requirement or
liability under any local or state plant closing notice Law. 
 (f) (i) All compensation, including wages, commissions and bonuses payable
to any Facility Employees for services performed on or prior to the date hereof have been paid in full or accrued in Seller’s financial records. Seller has withheld all amounts required by Law or agreement to be withheld from the wages or
salaries of Facility Employees and Buyer is not liable for any arrears of any Tax or penalties for Seller’s failure to comply with the foregoing. 

5.12 No Broker. Neither Seller nor any Person acting on behalf of Seller has paid or become obligated to pay any fee or commission to
any broker, finder or intermediary for or on account of the transactions contemplated by this Agreement 
 5.13 Employment Benefit
Matters. 
 (a) Seller has provided to Buyer a summary of each material benefit, retirement, compensation, incentive, bonus, stock
option, restricted stock, stock appreciation right, phantom equity, change in control, severance, vacation, paid time off, welfare and fringe-benefit agreement, plan, policy and program, whether or not reduced to writing, in effect and covering one
or more Facility Employees or the beneficiaries or dependents of any such Persons, which is maintained, sponsored, contributed to, or required to be contributed to by Seller, or under which Seller has any liability for premiums or benefits (each, a
“Benefit Plan”). 

  
 14 

 (b) Each Benefit Plan complies in all material respects with all applicable Laws, including
the Employee Retirement Income Security Act, as amended (“ERISA”) and the Internal Revenue Code of 1986, as amended (the “Code”). 

(c) There is no Liability whatsoever with respect to, or in any way related to, any Benefit Plan, which the Buyer shall assume, or could
reasonably be expected to assume (by operation of law or otherwise), as part of the transactions contemplated by this Agreement or otherwise. 

5.14 Benchmark Items. Schedule 5.14 sets forth the status of Seller’s obligations to satisfy certain benchmark requirements
as provided in the CCIDA Lease Agreements and the Alliance Agreement. 
 5.15 DISCLAIMER OF OTHER REPRESENTATIONS AND WARRANTIES.
EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, SELLER MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF THE PURCHASED ASSETS, THE ASSUMED LIABILITIES OR THE MANUFACTURING FACILITY, INCLUDING, WITHOUT
LIMITATION, WITH RESPECT TO MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, AND ANY SUCH OTHER REPRESENTATIONS OR WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED. 

ARTICLE VI 
 Representations and
Warranties of Buyer.  
 Buyer hereby makes the following representations and warranties to Seller as of the date hereof and as
of the Closing Date (except to the extent made only as of a specified date, in which case as of such date), which representations and warranties are qualified by the information set forth in the reports, registrations, documents, filings,
statements, schedules and submissions together with any required amendments thereto filed by Buyer with the SEC prior to the date of this Agreement. 

6.1 Organization and Good Standing. Buyer is a corporation duly organized, validly existing and in good standing under the laws of the
State of Delaware. 
 6.2 Due Authorization; No Conflict. 

(a) Buyer has all requisite power and authority to execute, deliver and perform this Agreement and all other Transaction Documents to which it
is a party, to consummate the transactions contemplated hereby and thereby and to perform its obligations hereunder and thereunder. The execution, delivery and performance by Buyer of this Agreement and all other Transaction Documents to which it is
a party have been duly authorized by all necessary corporate action. This Agreement, and all other Transaction Documents executed or to be executed by Buyer in connection herewith, constitute or, when executed and delivered, shall constitute, a
legal, valid and binding Contract of Buyer, enforceable against Buyer in accordance with its terms, except as enforcement may be limited by General Enforceability Exceptions. 

  
 15 

 (b) The execution and delivery by Buyer of this Agreement and the Transaction Documents to
which it is a party, the performance by Buyer of its obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby, shall not (with or without notice or lapse of time): (i) violate, conflict with,
result in a breach of the terms or conditions of, or constitute a default, an event of default or an event creating rights of acceleration, termination or cancellation or a loss of rights under, (A) any Contract to which Buyer is a party or by
which Buyer’s assets are subject or by which Buyer is bound, or (B) any Law, Governmental Authorization or Governmental Order applicable to Buyer or Buyer’s assets or business; (ii) contravene the Organizational Documents of
Buyer; (iii) require Buyer to make any declaration, filing or registration with, or provide any notice to, any Governmental Authority or obtain any Governmental Authorization, or (iv) require any consent, approval or authorization of,
declaration, filing or registration with, or notice to, any other Person. 
 6.3 Litigation. There is no Proceeding pending or, to
the Knowledge of Buyer, threatened against Buyer or its Affiliates which seeks to prohibit, restrict or delay consummation of the transactions contemplated by this Agreement or any of the conditions to consummation of such transactions. There
is no Governmental Order outstanding against Buyer or its Affiliates or, to the Knowledge of Buyer, threatened which seeks to prohibit, restrict or delay consummation of the transactions contemplated by this Agreement or any of the conditions to
consummation of such transactions. 
 6.4 No Brokers. Neither Buyer, nor any Person acting on behalf of Buyer, has paid or become
obligated to pay any fee or commission to any broker, finder or intermediary for or on account of the transactions contemplated by this Agreement. 

6.5 Independent Investigation. Buyer has conducted its own independent investigation, review and analysis of the Manufacturing
Facility, the Purchased Assets, and the Assumed Liabilities, and acknowledges that it has been provided adequate access to the personnel, properties, premises, and other documents and data of Seller for such purpose. Buyer acknowledges and agrees
that: (a) in making its decision to enter into this Agreement and consummate the transactions contemplated by this Agreement, Buyer has relied solely upon its own investigation and the express representations and warranties of Seller set forth
in Article V of this Agreement (including related portions of the Schedules); and (b) neither Seller nor any other Person has made any representation or warranty as to Seller, the Manufacturing Facility, the Purchased Assets, the Assumed
Liabilities, or this Agreement, except as expressly set forth in Article V of this Agreement (including the related portions of the Schedules). 

6.6 DISCLAIMER OF OTHER REPRESENTATIONS AND WARRANTIES. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, BUYER MAKES NO REPRESENTATION
OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF ANY OF ITS ASSETS, LIABILITIES OR OPERATIONS, INCLUDING, WITHOUT LIMITATION, WITH RESPECT TO MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, AND ANY SUCH OTHER
REPRESENTATIONS OR WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED. 
 ARTICLE VII 

Covenants and Agreements.  

  
 16 

 7.1 Buyer’s Investigation. 

(a) Prior to the Closing Date, Buyer shall be entitled, upon reasonable request and at its own expense, through its employees and
representatives, including without limitation, its attorneys to perform a due diligence evaluation of the Manufacturing Facility, the Purchased Assets, and the Assumed Liabilities. Buyer shall be permitted reasonable access to the Leased Premises
including, without limitation, the opportunity to observe and verify the Purchased Assets. Any such evaluation and review shall be conducted at reasonable times and under reasonable circumstances. Buyer agrees that any such evaluation or review
shall not unreasonably interfere with the ongoing operations of Sellers and shall not involve any Phase II environmental investigations, any environmental sampling or any other invasive investigations or sampling. Seller shall cooperate with all
reasonable requests and shall use reasonable efforts to cause its officers, employees, consultants, agents, accountants and attorneys to cooperate with such review and investigation. The furnishing of any information to Buyer or any investigation
made by Buyer or its authorized representatives shall not operate as a waiver or otherwise affect, diminish or obviate the representations and warranties made in this Agreement by Seller and Buyer’s right to rely thereon. 

(b) In the event this Agreement is terminated for any reason, upon the written request of Seller, Buyer shall promptly return to Seller or
destroy, any such information in its possession and certify in writing to Seller that it has done so, subject to the provisions of Section 10.3. The provisions of this Section 7.1(b) shall survive the termination of this Agreement. 

7.2 Consents of Third Parties; Governmental Authorizations. The Parties shall use best efforts to diligently pursue and secure, before
the Closing Date, all Seller Required Consents, in each case in form and substance agreed upon by Buyer and Seller. The Parties shall not willfully take any action that will have the effect of delaying, impairing or impeding the receipt of any
Seller Required Consents. Each of Buyer and Seller will comply with any reasonable additional requests for information by any Governmental Authority or other Person whose consent or approval is required for the Seller Required Consents. In addition,
Buyer and Seller will cooperate in good faith with any Governmental Authority or other such Person and use reasonable efforts to undertake promptly any reasonable action required to complete lawfully the transactions contemplated by this Agreement.
Buyer shall be responsible for and pay all fees and other charges that may be payable to any Governmental Authority for purposes of requesting or obtaining the Seller Required Consents, however, Seller shall be responsible for payment of any
penalties, fines, levies, assessments or charges, related to violations by Seller, that are required or conditioned upon obtaining the Seller Required Consents. Seller shall be responsible for and pay all fees and other charges that may be payable
to any Persons (other than Governmental Authorities) for purposes of requesting or obtaining the Seller Required Consents. If the Person identified as the “Design Builder” of Schedule 7.2 (“Design-Builder”) does not
consent to the assignment of the AIA Document A141-2014 (Standard Form of Agreement between Owner and Design-Builder) dated as of December 29, 2017, between Seller and Design-Builder, as amended or supplemented (the “AIA
Agreement”), to Buyer by the Closing Date, then Seller shall cooperate with Buyer to enforce any of Seller’s rights and obligations under the AIA Agreement post-Closing, at Buyer’s cost. 

7.3 Actions Prior to Closing. During the period prior to the Closing Date, except as contemplated by this Agreement or except as
approved in writing by Buyer, Seller shall (a) keep 

  
 17 

 
and maintain the Manufacturing Facility, the Leased Manufacturing Equipment, and the Owned Personal Property in good operating condition and repair subject to normal wear and tear;
(b) maintain and comply in all material respects with (except for expiration due to lapse of time) all Assigned Contracts in effect without change, except those Assigned Contracts which expire or terminate by their terms or as otherwise
expressly provided herein; (c) comply in all material respects with the provisions of all Laws applicable to the Manufacturing Facility and the Purchased Assets and its conduct of the Business; (d) not alter in any material respect the
rate or basis of compensation of any of the Facility Employees other than in the ordinary course of business; (e) use commercially reasonable efforts to resolve the matters identified in Schedule 5.10; (f) not sign any sublease or
license with respect to the Leased Real Property; (g) not amend the Lease Agreement or CCIDA Lease Agreements, or amend in any material respect any other Assigned Contract; (h) maintain insurance for the Leased Real Property (to the extent
maintained by Seller as of the date of this Agreement), Owned Personal Property and Leased Manufacturing Equipment; (i) refrain from removing any items of Owned Personal Property or Leased Manufacturing Equipment (other than any obsolete
items), unless such items are replaced with items of equal or greater value; (j) promptly inform Buyer of any written notices of default or violations that it receives related to the Leased Real Property, Manufacturing Facility or any Assigned
Contracts; (k) not enter into any agreements with Design-Builder or the “Architect” identified on Schedule 7.2 (“Architect”) without Buyer’s consent, which consent shall not be unreasonably withheld,
conditioned, or delayed; and (l) provide Buyer with the opportunity to attend all meetings and conference calls that Seller has with Design-Builder, Architect, FSMC, ESD, CCIDA or any Governmental Authority, to the extent such meetings or
conference calls relate to the Purchased Assets, Assigned Contracts, or the Manufacturing Facility. 
 7.4 Notification of Certain
Matters. 
 (a) From the date of this Agreement until the Closing Date, Seller shall give Buyer prompt written notice upon becoming
aware of any material development that has had or could reasonably be expected to adversely affect the Purchased Assets or the Assumed Liabilities, or any event or circumstance that has resulted in or could reasonably be expected to result in a
breach of, or inaccuracy in, any representation or warranty contained in Article V or the failure of any conditions set forth in Article VIII; provided, however, that no such disclosure shall be deemed to prevent or cure any
such breach of, or inaccuracy in, amend or supplement any Schedule to, or otherwise disclose any exception to, any of the representations and warranties of Seller set forth in this Agreement. 

(b) Seller and Buyer shall agree to a schedule of regular contact during the period prior to Closing to update Buyer on any matters related to
Section 7.3 or Section 7.4(a), and to keep a steady line of communication as it relates to Section 7.2. Seller shall update Buyer on a weekly basis regarding the status of (i) consummating Design-Builder’s obligations under
the AIA Agreement, and (ii) any Governmental Authority requisitions and payments related to the Manufacturing Facility. 
 7.5 No
Solicitation. From the date of this Agreement until the earlier of the Closing Date or the date of the termination of this Agreement pursuant to Article X, Seller shall not, and Seller shall not authorize or permit any officer, manager,
employee, investment banker, attorney or other adviser or representative of Seller to: (i) continue discussions, initiate, solicit, entertain, negotiate, accept or discuss, directly or indirectly, any proposal or offer from any Person or group

  
 18 

 
of persons other than Buyer and its Affiliates (a “Transaction Proposal”) to acquire all or any significant part of the Purchased Assets, whether by merger, purchase of stock,
purchase of assets, tender offer or otherwise, or (ii) enter into any agreement, arrangement or understanding requiring Seller to abandon, terminate or fail to consummate the transactions contemplated by this Agreement. 

7.6 Satisfaction of Closing Conditions. Seller and Buyer shall, and shall cause their respective representatives to, use best efforts
to take all of the actions necessary to consummate the transactions hereunder including delivering all the various certificates, documents and instruments described in Article VIII and Article IX hereto, as the case may be. 

7.7 Further Assurances. From and after the Closing Date, upon the request of either Seller or Buyer, each of the Parties shall do,
execute, acknowledge and deliver all such further acts, assurances, deeds, assignments, transfers, conveyances and other instruments and papers as may be commercially reasonable to carry out the transactions contemplated hereunder. 

7.8 Transfer of Warranties. As of the Closing Date, to the extent assignable, Seller shall be deemed to have assigned to Buyer all of
its right, title and interest in and to warranties (express and implied) that continue in effect with respect to any of the Purchased Assets or the Manufacturing Facility, and to have nominated Buyer as Seller’s true and lawful attorney to
enforce such warranties against such manufacturers, and Seller shall execute and deliver such specific assignments of such warranty rights as Buyer may reasonably request. 

7.9 Prorations. Personal property, ad valorem, use and intangible taxes and assessments, common area maintenance charges, utility
charges and rental payments with respect to the Purchased Assets and the Leased Real Property (collectively, “Charges”) shall be prorated on a per diem basis and apportioned on a calendar year basis between Seller, on the one hand,
and Buyer, on the other hand, as of the date of the Closing. Seller shall be liable for that portion of such Charges relating to, or arising in respect of, periods on or prior to the Closing Date, and Buyer shall be liable for that portion of such
Charges relating to, or arising in respect of, any period after the Closing Date. 
 7.10 Employees. 

(a) Effective as of immediately before the Closing, Buyer shall offer employment, on an “at will” basis and on terms of employment
substantially similar in the aggregate to the terms of employment currently provided by Seller, to all of Facility Employees; provided, that for purposes of determining whether such terms of employment are substantially similar in the
aggregate, equity compensation, employee pension benefit plan as defined in Section 3(2) of ERISA, severance, retention, sale, stay or change in control payments or awards or any similar compensation or benefit will not be taken into account.
Consistent with applicable Law, Seller shall provide Buyer access to the personnel records and personnel files of such Facility Employees, and shall provide such other information regarding the Facility Employees as Buyer may reasonably request. All
Facility Employees who accept such offers of employment with Buyer are hereinafter referred to as the “Transferred Employees” and such acceptance of offers shall be effective immediately after the Closing. 

  
 19 

 (b) With respect to any benefit plans, programs, and arrangements of Buyer in which
Transferred Employees participate after the Closing, Buyer shall use commercially reasonable efforts to: (i) waive all limitations as to pre-existing conditions, exclusions and waiting periods with
respect to participation and coverage requirements applicable to Transferred Employees under Buyer’s health and welfare plans to the extent such limitations were waived or otherwise satisfied under the comparable benefit plans,
(ii) recognize all service of Transferred Employees with Seller for purposes of eligibility to participate (but not benefit accruals), but only to the extent such service would be taken into account under a comparable benefit plan immediately
prior to the Closing, and (iii) to the extent permitted by Buyer’s health and welfare plans, provide that, with respect to the year in which the Closing occurs, any
year-to-date covered expenses incurred on or before the Closing by a Transferred Employee or a Transferred Employee’s covered dependent shall be taken into account
for purposes of satisfying applicable deductible, coinsurance and maximum out-of-pocket provisions after the Closing under Buyer’s health and welfare plans. 

(c) Seller shall be solely responsible for any Liability, claim or expense with respect to employment, termination of employment, compensation
or employee benefits of any nature owed to any Facility Employee (or the beneficiary of any such individual) whether or not such individual becomes a Transferred Employee, that arises out of or relates to the provision of services to or on behalf
of, or the employment relationship between, Seller and any such individual or the termination of such relationship or provision of services on or before the Closing Date. 

(d) For the purposes of the WARN Act and similar state and local laws, Buyer and Seller intend that the transactions contemplated by this
Agreement should not constitute a separation, employment loss, termination or severance of employment of any Facility Employee who accepts an employment offer by Buyer that is consistent with the requirements of Section 7.10(b) and that each
such Facility Employee will have continuous employment immediately before and immediately after the Closing. Buyer shall be liable for any Liabilities relating to Buyer’s hiring of the Transferred Employees and relating to the employment of any
Transferred Employees following the Closing. 
 (e) The provisions of this Section 7.10 are for the benefit of the Parties only and
shall not be construed to grant any rights, as a third party beneficiary or otherwise, to any Person who is not a party to this Agreement, nor shall any provision of this Agreement be deemed to be the adoption of, or an amendment to, any employee
benefit plan, or otherwise to limit the right of Buyer or Seller to amend, modify or terminate any such employee benefit plan. In addition, nothing contained herein shall be construed to (i) prohibit any amendments to or termination of any
employee benefit plans or (ii) prohibit the termination or change in terms of employment of any employee (including any Transferred Employee). Nothing herein, expressed or implied, shall confer upon any employee (including any Transferred
Employee) any rights or remedies (including, without limitation, any right to employment or continued employment for any specified period) of any nature or kind whatsoever, under or by reason of this Agreement. 

7.11 503B Agreement. During the period prior to the Closing Date, the Parties shall negotiate in good faith with respect to the
terms of a manufacturing agreement between the Buyer and the Seller (or an Affiliate or other designee thereof), in form and substance reasonably acceptable to Buyer and Seller, in respect of anticipated access to the Manufacturing Facility

  
 20 

 
consistent with the needs of the 503B business, under which Buyer shall agree to manufacture at the Manufacturing Facility certain products, following the Closing Date (the “503B
Agreement”). 
 7.12 Facility Records. 

(a) In order to facilitate the resolution of any claims made against or incurred by Seller prior to the Closing, or for any other reasonable
purpose, for a period of five (5) years after the Closing, Buyer shall: 
 (i) retain the Facility Records relating to periods prior
to the Closing in a manner reasonably consistent with the prior practices of Seller; and 
 (ii) upon reasonable notice, afford
Seller’s representatives reasonable access (including the right to make, at Seller’s expense, photocopies), during normal business hours, to such Facility Records. 

(b) In order to facilitate the resolution of any claims made by or against or incurred by Buyer after the Closing, or for any other reasonable
purpose, for a period of five (5) years following the Closing, Seller shall: 
 (i) retain the Facility Records of Seller which relate
to the business and its operations for periods prior to the Closing; and 
 (ii) upon reasonable notice, afford Buyer’s
representatives reasonable access (including the right to make, at Buyer’s expense, photocopies), during normal business hours, to such Facility Records. 

(c) Neither Buyer nor Seller shall be obligated to provide the other Party with access to any Facility Records pursuant to this Section
7.12 where such access would violate any Law. 
 ARTICLE VIII 

Conditions to Performance by Buyer Parties.  

The obligation of Buyer to consummate the Closing is subject to the fulfillment of each of the following conditions (unless waived by Buyer in
accordance with Section 12.4): 
 8.1 Representations and Warranties. Other than the Fundamental Representations of Seller, each
of the representations and warranties of Seller contained in this Agreement and in any document, instrument or certificate delivered pursuant to this Agreement, shall be true and correct in all respects (in the case of any representation or warranty
qualified by materiality) or true and correct in all material respects, (in the case of any representation or warranty not qualified by materiality), in either case, as of the date hereof and as of the Closing Date, other than representations and
warranties that expressly speak only as of a specific date or time, which shall be true and correct (or true and correct in all material respects, as the case may be) as of such specified date or time. The Fundamental Representations of Seller shall
be true and correct in all respects on and as of the date hereof and on and as of the date of the Closing with the same effect as though made at and as of such date (except those representations and warranties that address

  
 21 

 
matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all respects). 

8.2 Covenants and Agreements. Seller shall have performed and complied in all material respects with all of its obligations under this
Agreement which are to be performed or complied with by it prior to or at the Closing. 
 8.3 Compliance Certificate. Seller shall
have delivered to Buyer a certificate dated as of the Closing Date, duly executed by an officer of Seller, certifying as to the satisfaction or the conditions set forth in Sections 8.1 and 8.2. 

8.4 Absence of Litigation. No Proceeding shall be initiated, pending or threatened, verbally or in writing, nor shall there be any
formal or informal inquiry by a Governmental Authority, which may result in a Governmental Order (nor shall there be any Governmental Order in effect) which would prevent consummation of any of the transactions contemplated hereunder. 

8.5 Consents and Authorizations. All actions by (including any Governmental Authorization or consents of any other Persons) or in
respect of (including notice to), or filings with, any Governmental Authority or other Person that are required to consummate the transactions contemplated hereunder, and identified in Schedule 8.5 (the “Material Consents”)
shall have been obtained or made in a manner satisfactory in form and substance to Buyer. 
 8.6 Other Closing Deliveries. Seller
shall deliver or shall cause to be delivered to Buyer the following: 
 (a) a Bill of Sale, Assignment and Assumption Agreement or similar
document, in a form acceptable to Buyer and Seller (the “Bill of Sale”), duly executed by Seller; 
 (b) one or more
Assignment and Assumption Agreements or similar documents, in a form acceptable to Buyer and Seller, with respect to the Assigned Contracts, including, without limitation, an assignment of the Lease Agreement in recordable form (collectively, the
“Contract Assignments”), duly executed by Seller; 
 (c) an estoppel certificate, in form and substance reasonably
acceptable to Buyer which does not reveal any default, duly executed by FSMC; 
 (d) an estoppel certificate, in form and substance
reasonably acceptable to Buyer which does not reveal any default, duly executed by CCIDA; 
 (e) a certificate of good standing, as of a
recent date, of Seller from the State of Delaware and the State of New York; 
 (f) New York Real Property Transfer Tax returns with respect
to the Leased Real Property and the assignment of the Lease Agreement; and 
 (g) such other assignments and other instruments of transfer
or conveyance, duly executed by Seller, as may be reasonably requested by Buyer to effect the sale, conveyance and delivery of the Purchased Assets and Assumed Liabilities to Buyer. 

  
 22 

 ARTICLE IX 

Conditions to Performance by Seller.  

The obligations of Seller to consummate the Closing is subject to the fulfillment of each of the following conditions (unless waived by Seller
in accordance with Section 12.4): 
 9.1 Representations and Warranties. Other than the Fundamental Representations of Buyer,
each of the representations and warranties of Buyer contained in this Agreement shall be true and correct in all respects (in the case of any representation or qualified by materiality) or true and correct in all material respects (in the case of
any representation or warranty not qualified by materiality), in either case, as of the date hereof and as of the Closing Date, other than representations and warranties that expressly speak only as of a specific date or time, which shall be true
and correct (or true and correct in all material respects, as the case may be) as of such specified date or time. The Fundamental Representations of Buyer shall be true and correct in all respects on and as of the date hereof and on and as of the
date of the Closing with the same effect as though made at and as of such date (except those representations and warranties that address matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all
respects). 
 9.2 Covenants and Agreements. Buyer shall have performed and complied in all material respects with all of its
obligations under this Agreement which are to be performed or complied with by it prior to or at the Closing. 
 9.3 Compliance
Certificate. Buyer shall have delivered to Seller a certificate dated as of the Closing Date, duly executed by an officer of Buyer, certifying as to the satisfaction or the conditions set forth in Sections 9.1 and 9.2. 

9.4 Absence of Litigation. No Proceeding shall be pending or threatened in writing which may result in a Governmental Order (nor shall
there be any Governmental Order in effect) which would prevent consummation of any of the transactions contemplated hereunder. 
 9.5
Consents and Authorizations. All Material Consents shall have been obtained or made in a manner satisfactory in form and substance to Seller. 

9.6 Other Closing Deliveries. Buyer shall deliver or shall cause to be delivered to Seller the following: 

(a) payment of the Purchase Price, in accordance with Section 3.2; 

(b) the Bill of Sale, duly executed by Buyer; 

(c) the Contract Assignments, duly executed by Buyer; 

(d) a certificate of good standing, as of a recent date, of Buyer from the State of Delaware; and 

  
 23 

 (e) such other bills of sale, assignments and other instruments of transfer or conveyance,
duly executed by Buyer, as may be reasonably requested by Seller to effect the sale, conveyance and delivery of the Purchased Assets and Assumed Liabilities to Buyer. 

ARTICLE X 
 Termination.
 
 10.1 Termination. Notwithstanding anything contained in this Agreement to the contrary, this Agreement may be terminated at
any time prior to the Closing: 
 (a) by the mutual written consent of Buyer and Seller; 

(b) by either Buyer or Seller, if (i) any Governmental Authority having competent jurisdiction over any Party shall have issued a final
Governmental Order restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement and such Governmental Order is or shall have become nonappealable or (ii) there shall be adopted any Law that makes the
transactions contemplated by this Agreement illegal or otherwise prohibited; provided, however, the Party seeking to terminate this Agreement pursuant to clause (i) above shall not have initiated such Proceeding or taken any
action in support of such Proceeding and shall have used its reasonable best efforts to challenge such order or other action; 
 (c) by
Buyer, in the event of the inaccuracy in or breach of any representation or warranty of Seller contained in this Agreement or if Seller breaches or fails to perform any of its covenants or agreements contained in this Agreement and such inaccuracy,
breach or failure to perform (i) would reasonably be expected to give rise to the failure of a condition set forth in Article VIII, (ii) cannot be or has not been cured within twenty (20) Business Days after the receipt of written
notice thereof and (iii) has not been waived by Buyer; provided, that, the right to terminate this Agreement pursuant to this Section 10.1(c) shall not be available if, at the time of such purported termination, Buyer has breached
or failed to perform in any material respect any of its representations, warranties, covenants or agreements contained in this Agreement; or 

(d) by Seller, in the event of the inaccuracy in or breach of any representation or warranty of Buyer contained in this Agreement or if Buyer
breaches or fails to perform any of its covenants or agreements contained in this Agreement and such inaccuracy, breach or failure to perform (i) would reasonably be expected to give rise to the failure of a condition set forth in Article IX,
(ii) cannot be or has not been cured within twenty (20) Business Days after the receipt of written notice thereof and (iii) has not been waived by Seller; provided, that, the right to terminate this Agreement pursuant to this
Section 10.1(d) shall not be available if, at the time of such purported termination, Seller has breached or failed to perform in any material respect any of its representations, warranties, covenants or agreements contained in this Agreement.

 10.2 Notice of Termination; Effect of Termination. 

(a) The Party desiring to terminate this Agreement pursuant to Sections 10.1(b) through 10.1(d) shall give written notice of such termination
to the other Party in accordance with Section 12.8, specifying the provision or provisions hereof pursuant to which such termination is effected. The right of any Party to terminate this Agreement pursuant to Section 10.1 shall remain

  
 24 

 
operative and in full force and effect regardless of any investigation made by or on behalf of any Party hereto, whether prior to or after the execution of this Agreement. 

(b) In the event of termination of this Agreement pursuant to Section 10.1, this Agreement shall be of no further force or effect;
provided, however, (i) the provisions of Section 7.1(b), Article X, Article XI and Article XII shall survive termination and (ii) any termination pursuant to Section 10.1 shall not relieve any Party of any Liability for breach of
any representation, warranty, covenant or agreement hereunder occurring prior to such termination. 
 10.3 Return of Documentation.
Following termination of this Agreement, (a) all filings, applications and other submissions made pursuant to this Agreement or prior to the execution of this Agreement in contemplation hereof shall, to the extent practicable, be withdrawn from
the Governmental Authority to which made and (b) Buyer shall return or destroy (and provide proof of such destruction of) all agreements, documents, contracts, instruments, books, records, materials and other information (in any format)
regarding Seller provided to Buyer or its representatives in connection with the transactions contemplated hereunder other than as reasonably necessary to enforce its rights under this Agreement. Notwithstanding the foregoing, Buyer shall be
permitted to retain one copy of all such information and materials in its law department or with its outside legal counsel. 
 ARTICLE XI

 Indemnification.  

11.1 Survival of Representations and Warranties. All representations and warranties contained in this Agreement shall survive the
consummation of the transactions contemplated by this Agreement for a period of one year from the Closing Date; provided, however, that the representations and warranties contained in Sections 5.1, 5.2(a), 5.2(b), 5.3(a), and 5.12, and Sections 6.1,
6.2(a), and 6.4 (collectively, the “Fundamental Representations”) shall survive the consummation of the transactions contemplated by this Agreement for the full period of all applicable statutes of limitations (giving effect to any
waiver, mitigation or extension thereof) plus sixty (60) days. No action or claim for Losses resulting from any misrepresentation or breach of warranty shall be brought or made after the expiration of the survival period applicable to such
representation or warranty (as provided in this Section), except that such time limitation shall not apply to claims which have been asserted and which are the subject of a written notice from Seller to Buyer or from Buyer to Seller, as may be
applicable, prior to the expiration of such survival period. 
 11.2 Indemnification by Seller. Subject to the terms and conditions
of Section 11.4 and Section 11.5, Seller agrees to indemnify, defend and hold harmless Buyer and its successors and assigns (each a “Buyer Indemnitee”) from or against, for and in respect of, any and all damages, losses,
obligations, Liabilities, demands, judgments, injuries, penalties, claims, actions or causes of action, costs, and expenses (including, without limitation, reasonable attorneys’, experts’ and consultants’ fees) (collectively,
“Losses”) suffered, sustained, incurred or required to be paid by any Buyer Indemnitee arising out of, based upon, in connection with or as a result of: 

(a) any inaccuracy in or breach of any representation or warranty made by Seller in this Agreement; 

  
 25 

 (b) the non-fulfillment, non-performance or other breach of any covenant or agreement to be performed by Seller pursuant to this Agreement; 

(c) the Retained Liabilities; 

(d) any Taxes relating to any period prior to Closing, arising out of the Purchased Assets or Assumed Liabilities, other than any Transfer
Taxes that Buyer is responsible for under Section 12.1; or 
 (e) a bona fide Environmental Claim brought against Buyer by third
parties who are not Affiliates of Buyer, and who are not otherwise acting on behalf of Buyer or as a result of solicitation by or on behalf of Buyer, that (i) is a Material Environmental Liability and (ii) pertains to the Leased Real
Property and (A) pre-Closing Environmental Releases or (B) pre-Closing non-compliance with Environmental Laws;
provided, however, that Seller’s indemnity obligation pursuant to this Section 11.2(e) shall expire on the date that is five years from the Closing Date, except that such time limitation shall not apply to Claims which have been asserted
by Buyer and which are the subject of a written notice from Buyer to Seller prior to such expiration date. 
 11.3 Indemnification by
Buyer. Subject to the terms and conditions of Section 11.4 and Section 11.5, Buyer hereby agree to indemnify, defend and hold harmless Seller and its successors and assigns (each a “Seller Indemnitee”) from or against,
for and in respect of, any and all Losses suffered, sustained, incurred or required to by paid by any Seller Indemnitee arising out of, based upon, in connection with or as a result of: 

(a) any inaccuracy in or breach of any representation or warranty made by Buyer in this Agreement; 

(b) the non-fulfillment, non-performance or other breach of
any covenant or agreement to be performed by Buyer pursuant to this Agreement; or 
 (c) the Assumed Liabilities. 

11.4 Indemnification Procedures. 

(a) Any Party seeking indemnification hereunder (the “Indemnified Party”) shall promptly notify the other Party hereto (the
“Indemnifying Party”, which term shall include all Indemnifying Parties if there be more than one) of any claim for indemnification hereunder (a “Claim”), provided that failure of the Indemnified Party to
give such notice shall not relieve the Indemnifying Party of its obligations under this Article XI except to the extent, if at all, that such Indemnifying Party shall have been prejudiced thereby. After an Indemnified Party has delivered a Claim
requesting payment from an Indemnifying Party for any Losses, the Indemnifying Party shall, within thirty (30) days of receipt of such Claim, (i) pay to the Indemnified Party, in immediately available funds, the amount of Losses, or
(ii) deliver to the Indemnified Party written notice (a “Dispute Notice”) advising the Indemnifying Party that it disputes the Claim. If, within thirty (30) days of receipt of a Claim, the Indemnifying Party fails to pay
said amount to the Indemnified Party or deliver to the Indemnified Party a Dispute Notice the Indemnifying Party shall be deemed to have accepted and agreed to such Claim (a “Deemed Acceptance”) and the Indemnified Party may
exercise any and all legal or equitable remedies available to the 

  
 26 

 
Indemnified Party under this Agreement or otherwise with respect to such Losses. If, within such 30-day period following receipt of a Claim, the
Indemnifying Party delivers a Dispute Notice with respect to the Indemnified Party’s Claim, the Indemnifying Party and the Indemnified Party agree that, prior to commencing any litigation or other proceedings against the other concerning such
Claim, they will negotiate in good faith to resolve any dispute with respect to such Claim and to provide each other with all relevant information relating to such dispute. If the Indemnifying Party and the Indemnified Party are unable to resolve
any such dispute within thirty (30) days of the delivery of a Dispute Notice (or such longer period as the Parties may agree upon), the Indemnifying Party or the Indemnified Party may thereafter commence litigation or other proceedings to
resolve such dispute. The successful Party in any such proceeding shall be entitled to reimbursement from the non-successful Party for any and all of the successful Party’s costs and expenses including,
without limitation, reasonable attorneys’ fees, incurred in connection with such proceeding. Notwithstanding anything herein to the contrary, if any Claim relates to a Third Party Claim, the procedures of Section 11.4(b),
Section 11.4(c) and Section 11.4(d) shall apply to such Third Party Claim. 
 (b) If such Claim relates to any Proceeding or
demand instituted against the Indemnified Party by a third party (a “Third Party Claim”), the Indemnifying Party shall be entitled to participate in the defense of such Third Party Claim after receipt of notice of such Third Party
Claim from the Indemnified Party. Within thirty (30) days after receipt of notice of a Third Party Claim from the Indemnified Party, the Indemnifying Party may assume the defense of such Third Party Claim, in which case the Indemnifying Party
shall have the authority to negotiate, compromise and settle such Third Party Claim, if and only if the following conditions are satisfied: 

(i) the Indemnifying Party shall have confirmed in writing that it is obligated hereunder to indemnify the Indemnified Party with respect to
such Third Party Claim; 
 (ii) the Indemnified Party shall not have given the Indemnifying Party written notice that it has determined, in
the exercise of its reasonable discretion in good faith, that matters of corporate or management policy or a conflict of interest make separate representation by the Indemnified Party’s own counsel advisable; and 

(iii) such Third Party Claim involves only money damages and does not seek an injunction or other equitable relief; 

provided, however, that no Indemnifying Party shall, except with the consent of the Indemnified Party, consent to entry of any judgment or enter
into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all Liability in respect of such claim or litigation. Indemnified Party’s consent
shall not be unreasonably withheld with respect to monetary matters and matters that are not likely to adversely affect the business operations or reputation of the Indemnified Party. 

(c) In the event the Indemnifying Party does not elect, or is not entitled, to assume the defense of the Third Party Claim, the Indemnified
Party (upon further written notice to the Indemnifying Party) shall have the right to undertake the defense, compromise or settlement of such Third Party Claim, by counsel of its own choosing, on behalf of and for the account and at the risk of the
Indemnifying Party. 

  
 27 

 (d) Notwithstanding anything in this Section 11.4 to the contrary, the Indemnified
Party shall have the right, at its own cost and expense, to participate in the defense and, to the extent such participation affects the Indemnified Party, the compromise or settlement of the Third Party Claim. In the event the Indemnifying Party
undertakes defense of any Third Party Claim, the Indemnified Party, at its sole cost and expense, shall have the right to consult with the Indemnifying Party and its counsel concerning such Claim and the Indemnifying Party and the Indemnified Party
and their respective counsel shall cooperate with respect to the defense of such Claim. 
 11.5 Other Indemnification Provisions.

 (a) Subject to the provisions of Section 11.5(c), (i) the aggregate maximum amount of all Losses for which Seller shall be liable
pursuant to Section 11.2(a) related to Fundamental Representations shall not exceed the Purchase Price, and the aggregate maximum amount of all Losses for which Seller shall be liable pursuant to Section 11.2(a) related to all
representations and warranties other than Fundamental Representations shall not exceed an amount equal to 15% of the Purchase Price. 
 (b)
Subject to the provisions of 11.5(c), Seller shall not be obligated to provide any indemnification for Losses pursuant to Section 11.2(a) for claims for any inaccuracy in, or breach of, any representations and warranties (other than Fundamental
Representations) unless the aggregate amount of Losses incurred by the Buyer Indemnitees with respect to such breaches of, or inaccuracies in, representations and warranties exceeds $200,000 (the “Threshold”), in which case Seller
will be liable only for Losses in excess of the Threshold. 
 (c) The limitations set forth in Section 11.5(a) and Section 11.5(b)
shall not apply to Losses arising as a result of any fraud or intentional misrepresentation by Seller with respect to this Agreement. 
 (d)
The Parties acknowledge and agree that the indemnification provided in this Article XI is the exclusive remedy with respect to any Losses arising under or in connection with this Agreement; provided, however, that (i) any Party
may seek equitable relief, including the remedies of specific performance and injunction, with respect to the breach of any covenant or agreement to be performed after Closing, (ii) this Section 11.5(d) shall not apply with respect to any
claim based on fraud or intentional breach of this Agreement, and (iii) nothing contained in this Agreement shall impair or limit in any way the rights or remedies available to any Party under or in respect of the other Transaction Documents.
 
 (e) The Parties agree to treat any indemnity payments made pursuant to Sections 11.2 and 11.3 as an adjustment to the
Purchase Price for all tax purposes. 
 11.6 Insurance. In calculating the amount of Losses recoverable from an Indemnifying Party,
the amount of such Losses shall be reduced by the amount of any insurance proceeds actually received by the Indemnified Party in respect of the Losses net of (i) any deductible amounts and any reasonable costs and expenses actually incurred by
the Indemnified Party in collecting such insurance proceeds, including reasonable attorneys’ fees, and (ii) any increase in insurance premiums reasonably attributable to insurance proceeds paid in respect of such Losses. If an Indemnified
Party has been indemnified and made whole by the Indemnifying Party under 

  
 28 

 
this Agreement in respect of a Loss, and the Indemnified Party subsequently recovers any insurance proceeds in respect of such Loss, then the Indemnified Party shall promptly reimburse the
Indemnifying Party the amount of such indemnification payment that was subsequently recovered by such insurance proceeds, net of the adjustments described in the first sentence of this Section 11.6. 

11.7 Cooperation, Access to Documents and Information. The Parties shall cooperate with each other in connection with resolving any
indemnification Claims. Without limiting the generality of the foregoing, any Indemnified Party who asserts an indemnification Claim pursuant to this Agreement shall provide to the Indemnifying Party the right to inspect all reasonably requested
documents, books, records and other information relevant to the indemnification Claim and reasonably required to evaluate such indemnification Claim that are in the possession of the Indemnified Party or its Affiliates; provided,
however, that such right to inspect or access would not reasonably be expected to jeopardize or violate any attorney-client or other applicable legal privilege, applicable Law or Contract or other confidentiality obligations. 

ARTICLE XII 
 General
Provisions. 
 12.1 Expenses; Transfer Taxes. Whether or not the transactions contemplated herein shall be consummated,
except as otherwise expressly provided herein, the Parties shall pay their own respective expenses incident to the preparation of this Agreement and to the consummation of the transactions provided for herein. All transfer, documentary, sales, use,
stamp, registrations and other such taxes applicable to, imposed upon or arising out of the transactions contemplated hereby (collectively, “Transfer Taxes”) shall be paid by Buyer; provided, however, that with respect to real
property Transfer Taxes associated with the assignment of the Lease Agreement, Buyer shall not be required to pay more than $100,000 (and, if such real estate Transfer Taxes exceed $100,000, then Seller shall pay the balance thereof). 

12.2 Entire Agreement; No Third Party Beneficiaries; Amendment. This Agreement and the other Transaction Documents and the Exhibits and
Schedules thereto, embodies all of the representations, warranties and agreements of the Parties with respect to the subject matter hereof, and all prior understandings, representations and warranties (whether oral or written) with respect to such
matters are superseded. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person other than the Parties any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. This Agreement
may not be amended, modified, waived, discharged or orally terminated except by an instrument in writing signed by the Party against whom enforcement of the change, waiver, discharge or termination is sought. 

12.3 Severability. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other
provisions hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable provisions were omitted. Furthermore, in lieu of such illegal, invalid or unenforceable provisions there shall be added automatically as a
part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable. 

12.4 Waiver. Any Party to this Agreement may, by written notice to the other Parties, waive any provision of this Agreement from which
such Party is entitled to receive a benefit. The 

  
 29 

 
waiver by any Party hereto of a breach by another Party of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach by such other Party of such
provision or any other provision of this Agreement. 
 12.5 Public Announcements. Prior to the Closing Date, no public announcement
or other publicity regarding the existence of this Agreement or any agreements contemplated hereby or their contents or the transactions contemplated hereby or thereby shall be made by any Party or any of their respective Affiliates, officers,
directors, employees, representatives or agents, without the prior written agreement of the other Parties as to form, content, timing and manner of distribution or publication. On and after the Closing Date, each Party shall maintain confidential
the terms and provisions of this Agreement and the agreements contemplated hereby and the terms of the transactions contemplated hereby and thereby. Notwithstanding the foregoing, nothing in this Section 12.5 shall prevent any Party or its
Affiliates or any other Person from (a) making any public announcement or disclosure required by applicable Law or the rules of any stock exchange (in which case the disclosing Party will provide the other Party with the opportunity to review
and comment in advance of the disclosure); (b) disclosing this Agreement or any of the agreements contemplated hereby or their contents or the transactions contemplated hereby or thereby to (i) current and future officers, directors,
employees, representatives and agents of such Party and its Affiliates, (ii) current and potential lenders to, investors in and purchasers of such Party and its Affiliates, and (iii) any Governmental Authority in order to provide notice,
transfer any permits or licenses or obtain such Government Authorities consent in order to consummate the transaction contemplated by this Agreement; (c) disclosing the tax treatment and tax structure of the transactions contemplated hereby and
all materials of any kind (including opinions or other tax analyses) that are provided to such Party relating to such tax treatment and tax structure except to the extent maintaining confidentiality of such information is necessary to comply with
any applicable securities Laws; or (d) enforcing its rights hereunder. 
 12.6 Successors and Assigns. This Agreement shall not
be assignable by any Party hereto without the prior written consent of the other Parties; provided, however, Buyer may, upon written notice to Seller, assign this Agreement in whole or in part to any Affiliate of Buyer, provided that
such assignment shall not relieve Buyer of its obligations hereunder. This Agreement shall be binding upon, and shall inure to the benefit of, and be enforceable by, the Parties and their respective legal representatives, heirs, legatees, successors
and assigns.  
 12.7 Specific Performance. The Parties agree that irreparable damage would occur if any provision of this
Agreement were not performed in accordance with the terms hereof and that the Parties shall be entitled to specific performance of the terms hereof, including, but not limited to Section 7.5, in addition to any other remedy to which they are
entitled at law or in equity, in each case subject to the limitations set forth in this Agreement. 
 12.8 Notice. All notices or
other communications required or permitted hereunder shall be in writing and in English and shall be delivered personally or sent by registered or certified mail, by reputable overnight delivery or courier or by electronic mail or facsimile
transmission, addressed as follows: 

  
 30 

			
	To Buyer:	  	ImmunityBio, Inc.
		  	2040 E. Mariposa Avenue
		  	El Segundo, CA 90245
		  	Attn: Richard Adcock, CEO and President
		  	Email: Richard.Adcock@ImmunityBio.com
		
	With a copy to:	  	Olshan Frome Wolosky LLP
	(which shall not constitute notice)	  	1325 Avenue of the Americas
		  	New York, New York 10019
		  	Attn: Kenneth M. Silverman
		  	Facsimile No.: (212) 451-2222
		  	Email: ksilverman@olshanlaw.com
		
	To Seller:	  	Athenex, Inc.
		  	Conventus Building
		  	1001 Main Street, Suite 600
		  	Buffalo, NY 14203
		  	Attn: Legal Department
		  	Email: legal-agreements@athenex.com
		
	With a copy to:	  	Harter Secrest & Emery LLP
	(which shall not constitute notice)	  	1600 Bausch & Lomb Place
		  	Rochester, New York 14604-2711
		  	Attn: Alexander R. McClean
		  	Facsimile No.: (585) 232-2152
		  	E-mail: amcclean@hselaw.com

 and in any case at such other address as the advisee shall have specified by written notice. Notice of change of address shall
be effective only upon receipt thereof. All such other notices and communications shall be deemed effective (a) if by personal delivery, upon receipt, (b) if by registered or certified mail, on the seventh Business Day after the date of
mailing thereof, (c) if by reputable overnight delivery or courier, on the first Business Day after the date of mailing or (d) if by electronic mail or facsimile transmission, immediately upon receipt of a transmission confirmation,
provided notice is sent on a Business Day between the hours of 9:00 a.m. and 5:00 p.m., recipient’s time, but if not then upon the following Business Day. 

12.9 Counterparts; Facsimile Signatures. This Agreement may be executed in any number of counterparts, each of which when executed and
delivered shall be an original, but all such counterparts shall constitute one and the same instrument. The exchange of executed copies of this Agreement by facsimile, portable document format (PDF) or other reasonable form of electronic
transmission shall constitute effective execution and delivery of this Agreement. 
 12.10 Governing Law. This Agreement shall be
governed by and construed in accordance with the internal laws of the State of Delaware, without regard to conflicts-of-laws principles that would require application of
any other law. 

  
 31 

 12.11 Jurisdiction. Each Party hereby (a) agrees that any Proceeding in
connection with or relating to this Agreement, any agreement contemplated hereby or any matters contemplated hereby or thereby, shall be brought in a court of competent jurisdiction located in New Castle County in the State of Delaware, whether a
state or federal court; (b) agrees that in connection with any such Proceeding, such Party shall consent and submit to personal jurisdiction in any such court described in clause (a) of this Section 12.11 and to service of process
upon it in accordance with the rules and statutes governing service of process; and (c) agrees to waive to the full extent permitted by Law any objection that it may now or hereafter have to the venue of any such Proceeding in any such court or
that any such Proceeding was brought in an inconvenient forum. None of the Parties shall, and each Party shall cause its Affiliates not to, file, initiate or bring, or participate in, any Proceeding in connection with or relating to this Agreement
or any matters contemplated hereby in or before any Governmental Authority other than that specified in clause (a) of this Section 12.11. 

12.12 Interpretation. The use of the masculine, feminine or neuter gender or the singular or plural form of words used herein
(including defined terms) shall not limit any provision of this Agreement. The terms “include,” “includes” and “including” are not intended to be limiting and shall be deemed to be followed by the words “without
limitation” (whether or not they are in fact followed by such words) or words of like import. The term “or” has the inclusive meaning represented by the phrase “and/or.” Reference to a particular Person includes such
Person’s successors and assigns to the extent such successors and assigns are permitted by the terms of any applicable agreement. Reference to a particular agreement (including this Agreement), document or instrument means such agreement,
document or instrument as amended or modified and in effect from time to time in accordance with the terms thereof. The terms “dollars” and “$” mean United States Dollars. Unless Business Days are specified, all references to
“days” hereunder shall mean calendar days. The Exhibits and Schedules identified in this Agreement are incorporated into this Agreement by reference and made a part hereof. The Article, Section, paragraph, Exhibit and Schedule headings
contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. References to Articles, Sections, paragraphs, clauses, Exhibits or Schedules shall refer to those portions
of this Agreement. The use of the terms “hereunder,” “hereof,” “hereto” and words of similar import shall refer to this Agreement as a whole and not to any particular Article, Section, paragraph or clause of, or Exhibit
or Schedule to, this Agreement. 
 [Signature page follows.] 

  
 32 

 IN WITNESS WHEREOF, the Parties have executed this Asset Purchase Agreement as of the day
and year first above written. 
  

			
	SELLER:
	
	ATHENEX, INC.
		
	By:	 	/s/ Jeffrey Yordon
	Name:	 	Jeffrey Yordon
	Title:	 	Chief Operating Officer and President—Athenex Pharmaceutical Division

 [Signature Page to Asset Purchase Agreement] 

 
			
	BUYER:
	
	IMMUNITYBIO, INC.
		
	By:	 	/s/ Richard Adcock
	Name:	 	Richard Adcock
	Title:	 	Chief Executive Officer and President

 [Signature Page to Asset Purchase Agreement] 

 SCHEDULES 

Schedules: 
  

					
	Schedule 1.1	  	—  	  	Knowledge Parties
	Schedule 2.1(a)	  	—  	  	Leased Manufacturing Equipment
	Schedule 2.1(b)	  	—  	  	Owned Personal Property
	Schedule 2.1(d)	  	—  	  	Assigned Contracts
	Schedule 2.1(e)	  	—  	  	Seller’s Rights to Deposits and Prepayments
	Schedule 5.2(c)	  	—  	  	Seller Required Consents
	Schedule 5.3(a)	  	—  	  	Title to Owned Personal Property
	Schedule 5.4(a)	  	—  	  	Leased Real Property; Leases
	Schedule 5.4(b)	  		  	Events Affecting Costs
	Schedule 5.4(e)	  		  	Contractors
	Schedule 5.5	  	—  	  	Insurance
	Schedule 5.6	  	—  	  	Facility Governmental Authorizations
	Schedule 5.8(a)	  	—  	  	Environmental Matters
	Schedule 5.8(b)	  		  	Environmental Reports
	Schedule 5.9	  	—  	  	Litigation
	Schedule 5.10	  	—  	  	Breaches or Defaults Under Assigned Contracts
	Schedule 5.11(c)	  	—  	  	Facility Employee Proceedings
	Schedule 5.14	  	—  	  	Benchmark Items
	Schedule 7.2	  		  	Design-Builder and Architect
	Schedule 8.5	  	—  	  	List of Material Consents

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]